$169.98
-5.76-3.28%
Last update: Dec 16, 1:23 PM
Comments
Loading...
Biogen Insider Trading Activity | NASDAQ:BIIB | Benzinga
Track the latest Biogen insider trading activity. Stay informed on recent buys, sells, and market impact for Biogen stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Biogen Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Biogen Inc
Shares Outstanding
146.702M
Insider Shares Owned
2.185M
Insider Percentage Owned
1.49%
Institutional Shares Held
98.150M
Institutional Percentage Held
66.9%
| Sep 02, 2025 | Priya Singhal | HEAD DEVELOPMENT | 345.00 | $132.74 | -$175.75K | SELL-OPTIONS | 6.36% | 5.77K | Aug 29 - Sep 02 | View |
| Jul 16, 2025 | Rachid Izzar | HEAD GLOBAL PRODUCT STRAT. | -2.22K | $135.00 | -$300.11K | SELL | -25.99% | 6.33K | Jul 08 | View |
| May 20, 2025 | Priya Singhal | HEAD DEVELOPMENT | -3.81K | $126.25 | -$480.51K | SELL | -41.22% | 5.43K | May 19 | View |
| May 05, 2025 | Caroline Dorsa | DIRECTOR | 1.24K | $122.72 | $151.56K | BUY | 4.64% | 27.84K | May 02 | View |
| Mar 10, 2025 | Stephen Sherwin | DIRECTOR | -8.76K | $150.02 | -$1.31M | SELL | -43.63% | 11.32K | Mar 07 | View |
| Dec 09, 2024 | Priya Singhal | HEAD DEVELOPMENT | 110.00 | $157.58 | -$49.80K | SELL-OPTIONS | 2.07% | 5.43K | Dec 06 - Dec 09 | View |
| Sep 05, 2024 | Priya Singhal | HEAD DEVELOPMENT | 430.00 | $204.57 | -$253.26K | SELL-OPTIONS | 8.80% | 5.32K | Aug 30 - Sep 03 | View |
| Apr 03, 2024 | Priya Singhal | HEAD DEVELOPMENT | -93.00 | $213.09 | -$19.82K | SELL | -1.87% | 4.89K | Apr 02 | View |
| Feb 26, 2024 | Priya Singhal | HEAD DEVELOPMENT | -262.00 | $221.23 | -$57.96K | SELL | -5.09% | 4.89K | Feb 22 | View |
| Feb 21, 2024 | Priya Singhal | HEAD DEVELOPMENT | 632.00 | $219.53 | -$126.45K | SELL-OPTIONS | 13.99% | 5.15K | Feb 16 | View |
| Feb 20, 2024 | Eric K Rowinsky | DIRECTOR | 455.00 | $222.54 | $101.26K | BUY | 2.26% | 20.63K | Feb 15 | View |
| Feb 13, 2024 | Priya Singhal | HEAD DEVELOPMENT | 419.00 | $240.17 | -$190.46K | SELL-OPTIONS | 10.23% | 4.52K | Feb 09 - Feb 12 | View |
| Feb 05, 2024 | Priya Singhal | HEAD DEVELOPMENT | 633.00 | $246.82 | -$294.95K | SELL-OPTIONS | 18.27% | 4.10K | Feb 01 - Feb 02 | View |
| Dec 12, 2023 | Priya Singhal | HEAD DEVELOPMENT | 110.00 | $242.32 | -$76.57K | SELL-OPTIONS | 3.28% | 3.46K | Dec 08 - Dec 11 | View |
| Sep 06, 2023 | Priya Singhal | HEAD DEVELOPMENT | 430.00 | $267.96 | -$331.73K | SELL-OPTIONS | 14.71% | 3.35K | Sep 01 - Sep 05 | View |
| Jul 05, 2023 | Priya Singhal | HEAD DEVELOPMENT | 81.00 | $284.16 | -$66.49K | SELL-OPTIONS | 2.85% | 2.92K | Jun 30 - Jul 03 | View |
| May 02, 2023 | Ginger Gregory | EVP, HUMAN RESOURCES | -2.68K | $300.00 | -$804.30K | SELL | -24.02% | 8.48K | Apr 28 | View |
| Apr 06, 2023 | Priya Singhal | HEAD DEVELOPMENT | -91.00 | $277.11 | -$25.22K | SELL | -3.10% | 2.84K | Apr 04 | View |
| Mar 30, 2023 | Priya Singhal | HEAD DEVELOPMENT | -568.00 | $270.06 | -$153.39K | SELL | -16.65% | 2.84K | Mar 28 | View |
| Dec 12, 2022 | Ginger Gregory | EVP, HUMAN RESOURCES | -5.61K | $300.11 | -$1.68M | SELL | -49.55% | 5.71K | Nov 14 | View |
| Oct 28, 2022 | Susan Alexander | EVP CHIEF LEGAL OFF & CORP SEC | -5.53K | $280.70 | -$1.55M | SELL | -12.31% | 39.40K | Oct 27 | View |
| Jun 09, 2021 | Alfred Sandrock | HEAD RESEARCH & DEVELOPMENT | -7.67K | $440.00 | -$3.38M | SELL | -43.00% | 10.17K | Jun 07 | View |
| Jun 09, 2021 | Chirfi Guindo | HEAD GLOB PROD STRAT & COM | -3.09K | $440.00 | -$1.36M | SELL | -51.40% | 2.92K | Jun 07 | View |
| Jun 07, 2021 | Brian S Posner | DIRECTOR | -360.00 | $274.17 | -$98.70K | SELL | -4.64% | 7.40K | Jun 04 | View |
| Feb 10, 2021 | Jesus B Mantas | DIRECTOR | 898.00 | $267.00 | $239.77K | BUY | 43.91% | 2.94K | Feb 09 | View |
| Dec 01, 2020 | Michel Vounatsos | — | 3.10K | $241.31 | $748.05K | PURCHASE | 9.78% | 34.81K | Nov 30 | View |
| Nov 06, 2020 | Alfred Sandrock | — | -1.50K | $350.00 | -$525.00K | SELL | -10.30% | 13.07K | Nov 04 | View |
| Mar 12, 2020 | Stephen Sherwin | — | 9.84K | $176.84 | -$801.68 | OPTION EXERCISE | 175.97% | 15.44K | Mar 11 | View |
| Dec 03, 2019 | Brian S Posner | DIRECTOR | -1.05K | $292.35 | -$308.43K | SELL | -13.11% | 7.00K | Dec 02 | View |
| May 02, 2019 | Alexander J Denner | DIRECTOR | 118.34K | $229.94 | $27.21M | BUY | 22.10% | 653.91K | Apr 30 - May 02 | View |
| May 02, 2019 | Michel Vounatsos | CHIEF EXECUTIVE OFFICER | 4.35K | $231.48 | $1.01M | BUY | 26.12% | 21.01K | May 01 | View |
| Mar 19, 2019 | Robert W Pangia | DIRECTOR | 0.00 | $190.39 | -$1.69M | SELL-OPTIONS | 0.00% | 18.59K | Mar 18 | View |
| Feb 01, 2019 | Alexander J Denner | DIRECTOR | 62.80K | $327.59 | $20.57M | BUY | 13.28% | 535.57K | Jan 30 - Feb 01 | View |
| Sep 27, 2018 | Michael D Ehlers | EVP, RESEARCH AND DEVELOPMENT | -1.00K | $350.00 | -$350.00K | SELL | -18.94% | 4.28K | Sep 26 | View |
| Apr 27, 2018 | Alexander J Denner | DIRECTOR | 48.00K | $269.91 | $12.96M | BUY | 11.32% | 471.89K | Apr 25 | View |
| Feb 28, 2018 | Alfred Sandrock | EVP, CHIEF MEDICAL OFFICER | -259.00 | $290.83 | -$75.32K | SELL | -3.80% | 6.55K | Feb 27 | View |
| Feb 27, 2018 | Alfred Sandrock | EVP, CHIEF MEDICAL OFFICER | -649.00 | $293.32 | -$327.34K | SELL | -8.70% | 6.81K | Feb 23 | View |
| Feb 21, 2018 | Alfred Sandrock | EVP, CHIEF MEDICAL OFFICER | -743.00 | $292.00 | -$216.96K | SELL | -10.18% | 6.55K | Feb 20 | View |
| Feb 20, 2018 | Alfred Sandrock | EVP, CHIEF MEDICAL OFFICER | -1.29K | $298.85 | -$386.71K | SELL | -15.06% | 7.30K | Feb 15 | View |
| Jan 10, 2018 | Robert W Pangia | DIRECTOR | 0.00 | $193.74 | -$1.59M | SELL-OPTIONS | 0.00% | 17.71K | Jan 09 | View |
| Jan 02, 2018 | Michel Vounatsos | CHIEF EXECUTIVE OFFICER | 780.00 | $320.55 | $250.03K | BUY | 19.03% | 4.88K | Dec 29 | View |
| Nov 30, 2017 | Alexander J Denner | DIRECTOR | 30.00K | $317.36 | $9.52M | BUY | 7.62% | 423.89K | Nov 28 - Nov 29 | View |
| Jul 26, 2017 | Susan Alexander | EVP CHIEF LEGAL CORP SVC & SEC | -4.97K | $290.01 | -$1.44M | SELL | -18.27% | 22.26K | Jul 25 | View |
| Jul 20, 2017 | Susan Alexander | EVP CHIEF LEGAL CORP SVC & SEC | -7.76K | $285.00 | -$2.21M | SELL | -22.17% | 27.23K | Jul 19 | View |
| Jun 12, 2017 | Brian S Posner | DIRECTOR | -1.08K | $256.31 | -$277.84K | SELL | -14.62% | 6.33K | Jun 09 | View |
| May 02, 2017 | Michel Vounatsos | CHIEF EXECUTIVE OFFICER | 1.40K | $271.35 | $380.43K | BUY | 91.91% | 2.93K | May 01 | View |
| May 01, 2017 | Alexander J Denner | DIRECTOR | 73.86K | $278.50 | $20.57M | BUY | 23.15% | 392.83K | Apr 27 | View |
| Apr 27, 2017 | Paul Clancy | EXECUTIVE VP AND CFO | -9.89K | $290.00 | -$2.87M | SELL | -47.78% | 10.81K | Apr 25 | View |
| Apr 04, 2017 | Alfred Sandrock | EVP CMO NEURO & NEURODEGENERAT | -1.98K | $274.08 | -$542.95K | SELL | -21.91% | 7.06K | Apr 03 | View |
| Mar 14, 2017 | Paul Clancy | EXECUTIVE VP AND CFO | -9.89K | $291.55 | -$2.88M | SELL | -32.33% | 20.70K | Mar 13 | View |
| Mar 03, 2017 | Alfred Sandrock | EVP CMO NEURO & NEURODEGENERAT | -973.00 | $290.07 | -$282.24K | SELL | -9.72% | 9.04K | Mar 01 | View |
| Mar 01, 2017 | Michel Vounatsos | CHIEF EXECUTIVE OFFICER | 1.33K | $285.39 | $380.42K | BUY | 1320.70% | 1.43K | Feb 27 | View |
| Jan 10, 2017 | Robert W Pangia | DIRECTOR | 0.00 | $173.81 | -$1.33M | SELL-OPTIONS | 0.00% | 16.63K | Jan 09 | View |
| Dec 05, 2016 | Adriana Karaboutis | EVP, TECH, BUS. SOL & CORP AFF | -219.00 | $295.94 | -$64.81K | SELL | -2.89% | 7.36K | Dec 01 | View |
| Oct 05, 2016 | Adriana Karaboutis | EVP, TECH, BUS. SOL & CORP AFF | -262.00 | $311.94 | -$81.73K | SELL | -3.34% | 7.58K | Oct 04 | View |
| Oct 04, 2016 | Adriana Karaboutis | EVP, TECH, BUS. SOL & CORP AFF | -286.00 | $313.02 | -$709.94K | SELL | -3.52% | 7.84K | Oct 01 - Oct 03 | View |
| Sep 26, 2016 | Caroline Dorsa | DIRECTOR | 0.00 | $183.82 | -$7.18M | SELL-OPTIONS | 0.00% | 17.09K | Sep 22 | View |
| Jul 22, 2016 | George A Scangos | CHIEF EXECUTIVE OFFICER | -157.00 | $280.00 | -$43.96K | SELL | -0.26% | 60.16K | Jul 21 | View |
| Jun 07, 2016 | Adam Koppel | EVP, STRATEGY AND BUS. DEV. | -555.00 | $290.00 | -$160.95K | SELL | -18.77% | 2.40K | Jun 06 | View |
| Jun 06, 2016 | George A Scangos | CHIEF EXECUTIVE OFFICER | -842.00 | $290.00 | -$244.18K | SELL | -1.38% | 60.31K | Jun 03 | View |
| Jun 02, 2016 | George A Scangos | CHIEF EXECUTIVE OFFICER | -3.85K | $289.74 | -$1.12M | SELL | -5.93% | 61.16K | May 31 - Jun 01 | View |
| May 27, 2016 | George A Scangos | CHIEF EXECUTIVE OFFICER | -157.00 | $280.00 | -$43.96K | SELL | -0.24% | 65.01K | May 25 | View |
| May 04, 2016 | George A Scangos | CHIEF EXECUTIVE OFFICER | -487.00 | $274.74 | -$133.80K | SELL | -0.74% | 65.17K | May 02 | View |
| Apr 07, 2016 | Adam Koppel | EVP, STRATEGY AND BUS. DEV. | -102.00 | $275.00 | -$28.05K | SELL | -5.23% | 1.85K | Apr 06 | View |
| Apr 07, 2016 | George A Scangos | CHIEF EXECUTIVE OFFICER | -157.00 | $280.00 | -$43.96K | SELL | -0.24% | 65.66K | Apr 06 | View |
| Apr 05, 2016 | George A Scangos | CHIEF EXECUTIVE OFFICER | -487.00 | $258.83 | -$126.05K | SELL | -0.73% | 65.81K | Apr 01 | View |
| Mar 03, 2016 | George A Scangos | CHIEF EXECUTIVE OFFICER | -487.00 | $261.37 | -$127.29K | SELL | -0.73% | 66.30K | Mar 01 | View |
| Feb 26, 2016 | Alfred Sandrock | EVP CMO NEURO & NEURODEGENERAT | -183.00 | $261.90 | -$47.93K | SELL | -2.24% | 7.99K | Feb 25 | View |
| Feb 26, 2016 | Adriana Karaboutis | EVP, TECH, BUS. SOL & CORP AFF | -84.00 | $261.90 | -$22.00K | SELL | -1.02% | 8.13K | Feb 25 | View |
| Feb 19, 2016 | George A Scangos | CHIEF EXECUTIVE OFFICER | -487.00 | $256.16 | -$124.75K | SELL | -0.74% | 65.23K | Feb 17 | View |
| Feb 19, 2016 | Alfred Sandrock | EVP CMO NEURO & NEURODEGENERAT | -722.00 | $256.16 | -$184.95K | SELL | -8.29% | 7.99K | Feb 17 | View |
| Feb 10, 2016 | Alfred Sandrock | EVP CMO NEURO & NEURODEGENERAT | 0.00 | $247.95 | -$316.88K | SELL-OPTIONS | 0.00% | 7.74K | Feb 08 - Feb 09 | View |
| Dec 07, 2015 | Alfred Sandrock | EVP CMO NEURO & NEURODEGENERAT | -834.00 | $276.26 | -$230.40K | SELL | -9.73% | 7.74K | Dec 03 - Dec 04 | View |
| Dec 03, 2015 | Adriana Karaboutis | EVP, TECH. AND BUS. SOLUTIONS | -219.00 | $289.84 | -$63.48K | SELL | -2.71% | 7.88K | Dec 01 - Dec 02 | View |
| Oct 26, 2015 | Alexander J Denner | DIRECTOR | 310.00K | $277.47 | $86.02M | BUY | 3929.02% | 317.89K | Oct 22 - Oct 23 | View |
| Oct 06, 2015 | Adriana Karaboutis | EVP, TECH. AND BUS. SOLUTIONS | -269.00 | $291.43 | -$78.39K | SELL | -3.22% | 8.09K | Oct 05 | View |
| Oct 05, 2015 | Adriana Karaboutis | EVP, TECH. AND BUS. SOLUTIONS | -144.00 | $286.52 | -$596.81K | SELL | -1.69% | 8.36K | Oct 01 - Oct 02 | View |
| Jul 27, 2015 | Stelios Papadopoulos | DIRECTOR | 10.00K | $304.88 | $3.05M | BUY | 86.36% | 21.58K | Jul 27 | View |
| Jun 23, 2015 | Brian S Posner | DIRECTOR | -470.00 | $415.00 | -$195.05K | SELL | -8.18% | 5.28K | Jun 22 | View |
| Jun 22, 2015 | Douglas E Williams | EVP RESEARCH & DEVELOPMENT | -3.84K | $410.00 | -$1.57M | SELL | -24.53% | 11.82K | Jun 19 | View |
| Jun 16, 2015 | Brian S Posner | DIRECTOR | -400.00 | $386.64 | -$154.66K | SELL | -6.51% | 5.75K | Jun 15 | View |
| Jun 02, 2015 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.36K | $398.87 | -$543.26K | SELL | -2.85% | 46.47K | Jun 01 | View |
| May 05, 2015 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.36K | $377.52 | -$514.18K | SELL | -2.77% | 47.83K | May 01 | View |
| Apr 02, 2015 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.36K | $423.20 | -$576.40K | SELL | -2.69% | 49.19K | Apr 01 | View |
| Mar 30, 2015 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | -430.00 | $430.12 | -$184.95K | SELL | -4.78% | 8.57K | Mar 27 | View |
| Mar 26, 2015 | John Cox | EVP PHARMACEUTICAL OPER & TECH | -6.94K | $257.45 | -$5.06M | SELL | -21.36% | 25.57K | Mar 25 | View |
| Mar 23, 2015 | Eric K Rowinsky | DIRECTOR | 0.00 | $267.41 | -$4.84M | SELL-OPTIONS | 0.00% | 11.31K | Mar 20 | View |
| Mar 20, 2015 | Eric K Rowinsky | DIRECTOR | 0.00 | $247.98 | -$877.95K | SELL-OPTIONS | 0.00% | 11.31K | Mar 19 | View |
| Mar 18, 2015 | Eric K Rowinsky | DIRECTOR | 0.00 | $242.64 | -$1.71M | SELL-OPTIONS | 0.00% | 11.31K | Mar 17 | View |
| Mar 17, 2015 | Kenneth DiPietro | EVP HUMAN RESOURCES | -803.00 | $415.46 | -$333.61K | SELL | -100.00% | 0.00 | Mar 16 | View |
| Mar 16, 2015 | George A Scangos | CHIEF EXECUTIVE OFFICER | -537.00 | $412.69 | -$221.61K | SELL | -1.05% | 50.55K | Mar 13 | View |
| Mar 11, 2015 | Stephen Sherwin | DIRECTOR | -275.00 | $234.75 | -$2.10M | SELL | -6.21% | 4.15K | Mar 06 - Mar 10 | View |
| Mar 11, 2015 | Eric K Rowinsky | DIRECTOR | 0.00 | $238.53 | -$1.67M | SELL-OPTIONS | 0.00% | 11.31K | Mar 09 | View |
| Mar 11, 2015 | Robert W Pangia | DIRECTOR | 0.00 | $230.56 | -$1.33M | SELL-OPTIONS | 0.00% | 14.87K | Mar 10 | View |
| Mar 03, 2015 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | -6.00K | $409.54 | -$2.46M | SELL | -39.99% | 9.00K | Mar 01 - Mar 02 | View |
| Mar 03, 2015 | George A Scangos | CHIEF EXECUTIVE OFFICER | -825.00 | $410.67 | -$338.80K | SELL | -1.59% | 51.09K | Mar 02 | View |
| Feb 20, 2015 | George A Scangos | CHIEF EXECUTIVE OFFICER | -537.00 | $401.04 | -$215.36K | SELL | -1.02% | 51.92K | Feb 19 | View |
| Feb 18, 2015 | George A Scangos | CHIEF EXECUTIVE OFFICER | -825.00 | $389.11 | -$321.02K | SELL | -1.55% | 52.45K | Feb 17 | View |
| Feb 18, 2015 | Steven H Holtzman | EVP CORPORATE DEVELOPMENT | -2.13K | $389.11 | -$828.03K | SELL | -33.00% | 4.32K | Feb 17 | View |
| Feb 18, 2015 | Kenneth DiPietro | EVP HUMAN RESOURCES | -1.19K | $389.11 | -$462.26K | SELL | -59.67% | 803.00 | Feb 17 | View |
| Feb 18, 2015 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | -418.00 | $389.11 | -$162.65K | SELL | -2.71% | 15.00K | Feb 17 | View |
| Feb 11, 2015 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | -1.14K | $398.11 | -$455.04K | SELL | -7.27% | 14.57K | Feb 10 | View |
| Feb 10, 2015 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | 1.14K | $398.49 | -$780.25K | SELL-OPTIONS | 7.84% | 15.72K | Feb 08 - Feb 09 | View |
| Feb 03, 2015 | Kenneth DiPietro | EVP HUMAN RESOURCES | -1.66K | $389.03 | -$644.23K | SELL | -100.00% | 0.00 | Feb 02 | View |
| Dec 16, 2014 | Spyridon ArtavanisTsakonas | SVP, CHIEF SCIENTIFIC OFFICER | -1.98K | $346.50 | -$686.42K | SELL | -84.91% | 352.01 | Dec 15 | View |
| Dec 05, 2014 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | -833.00 | $346.57 | -$288.69K | SELL | -5.41% | 14.57K | Dec 03 - Dec 04 | View |
| Dec 03, 2014 | Steven H Holtzman | EVP CORPORATE DEVELOPMENT | -1.75K | $335.65 | -$587.05K | SELL | -100.00% | 0.00 | Dec 02 | View |
| Nov 12, 2014 | Steven H Holtzman | EVP CORPORATE DEVELOPMENT | -1.75K | $330.00 | -$577.50K | SELL | -50.01% | 1.75K | Nov 11 | View |
| Nov 04, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.13K | $320.78 | -$361.84K | SELL | -4.61% | 23.36K | Nov 03 | View |
| Oct 02, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.13K | $330.97 | -$373.00K | SELL | -4.40% | 24.49K | Oct 01 | View |
| Oct 02, 2014 | Steven H Holtzman | EVP CORPORATE DEVELOPMENT | -1.75K | $330.97 | -$579.20K | SELL | -33.34% | 3.50K | Oct 01 | View |
| Sep 04, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.13K | $345.47 | -$389.69K | SELL | -4.22% | 25.62K | Sep 02 | View |
| Aug 04, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.13K | $332.93 | -$375.55K | SELL | -4.05% | 26.75K | Aug 01 | View |
| Jul 18, 2014 | George Scangos | CHIEF EXECUTIVE OFFICER | -12.32K | $312.37 | -$3.85M | SELL | -30.64% | 27.87K | Jul 16 | View |
| Jun 23, 2014 | Brian S Posner | DIRECTOR | -605.00 | $315.00 | -$190.57K | SELL | -9.16% | 6.00K | Jun 20 | View |
| Jun 16, 2014 | Brian S Posner | DIRECTOR | 170.00 | $310.50 | -$217.35K | GRANT | 2.64% | 6.61K | Jun 12 - Jun 13 | View |
| Jun 03, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -484.00 | $318.93 | -$154.36K | SELL | -1.65% | 28.91K | Jun 02 | View |
| May 20, 2014 | Steven H Holtzman | EVP CORPORATE DEVELOPMENT | -1.22K | $289.15 | -$353.05K | SELL | -17.52% | 5.75K | May 19 | View |
| May 02, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.12K | $285.56 | -$606.24K | SELL | -6.74% | 29.40K | May 01 | View |
| Apr 21, 2014 | Steven H Holtzman | EVP CORPORATE DEVELOPMENT | -1.22K | $291.00 | -$355.31K | SELL | -14.91% | 6.97K | Apr 17 | View |
| Apr 02, 2014 | Robert W Pangia | DIRECTOR | 0.00 | $177.99 | -$1.63M | SELL-OPTIONS | 0.00% | 14.00K | Apr 01 | View |
| Apr 02, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.12K | $308.42 | -$654.78K | SELL | -6.31% | 31.52K | Apr 01 | View |
| Apr 01, 2014 | Brian S Posner | DIRECTOR | -3.00K | $296.76 | -$890.27K | SELL | -31.80% | 6.43K | Mar 31 | View |
| Mar 21, 2014 | Caroline Dorsa | DIRECTOR | 0.00 | $201.26 | -$2.95M | SELL-OPTIONS | 0.00% | 14.47K | Mar 20 | View |
| Mar 21, 2014 | Douglas E Williams | EVP RESEARCH & DEVELOPMENT | -3.50K | $352.29 | -$1.23M | SELL | -30.53% | 7.98K | Mar 19 | View |
| Mar 18, 2014 | Steven H Holtzman | EVP CORPORATE DEVELOPMENT | -1.22K | $334.83 | -$408.83K | SELL | -12.97% | 8.19K | Mar 17 | View |
| Mar 12, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -26.12K | $333.77 | -$8.72M | SELL | -43.71% | 33.64K | Mar 10 | View |
| Mar 12, 2014 | Nancy Leaming | DIRECTOR | -2.00K | $327.65 | -$655.30K | SELL | -20.70% | 7.66K | Mar 10 | View |
| Mar 12, 2014 | Stuart A Kingsley | EVP, GLOBAL COMM. OPERATIONS | -8.43K | $336.83 | -$2.84M | SELL | -70.59% | 3.51K | Mar 11 | View |
| Mar 05, 2014 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | -3.17K | $342.58 | -$1.09M | SELL | -17.07% | 15.41K | Mar 04 | View |
| Mar 04, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.94K | $335.79 | -$987.89K | SELL | -4.69% | 59.77K | Mar 03 | View |
| Feb 27, 2014 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | -1.05K | $342.17 | -$358.59K | SELL | -4.67% | 21.41K | Feb 26 | View |
| Feb 19, 2014 | Steven H Holtzman | EVP CORPORATE DEVELOPMENT | -1.22K | $327.90 | -$400.69K | SELL | -11.49% | 9.41K | Feb 18 | View |
| Feb 14, 2014 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | 7.74K | $319.49 | -$253.03K | SELL-OPTIONS | 56.63% | 21.41K | Feb 12 - Feb 13 | View |
| Feb 14, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | 4.37K | $322.41 | -$1.55M | SELL-OPTIONS | 7.49% | 62.71K | Feb 12 - Feb 13 | View |
| Feb 14, 2014 | Kenneth DiPietro | EVP HUMAN RESOURCES | 0.00 | $319.46 | -$717.51K | SELL-OPTIONS | 0.00% | 0.00 | Feb 12 - Feb 13 | View |
| Feb 12, 2014 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | -2.08K | $314.31 | -$655.34K | SELL | -13.24% | 13.67K | Feb 11 | View |
| Feb 12, 2014 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.46K | $314.31 | -$771.95K | SELL | -4.04% | 58.34K | Feb 11 | View |
| Feb 05, 2014 | Kenneth DiPietro | EVP HUMAN RESOURCES | -1.66K | $299.01 | -$494.86K | SELL | -100.00% | 0.00 | Feb 04 | View |
| Jan 22, 2014 | Eric K Rowinsky | DIRECTOR | -2.02K | $310.09 | -$626.38K | SELL | -16.21% | 10.44K | Jan 21 | View |
| Jan 16, 2014 | Lynn Schenk | DIRECTOR | -1.00K | $297.48 | -$297.48K | SELL | -13.47% | 6.42K | Jan 15 | View |
| Jan 09, 2014 | William Young | DIRECTOR | -15.00K | $285.11 | -$4.28M | SELL | -44.76% | 18.51K | Jan 08 | View |
| Jan 07, 2014 | Robert W Pangia | DIRECTOR | 0.00 | $162.79 | -$1.44M | SELL-OPTIONS | 0.00% | 14.00K | Jan 06 | View |
| Jan 06, 2014 | Stephen Sherwin | DIRECTOR | 0.00 | $169.55 | -$1.21M | SELL-OPTIONS | 0.00% | 3.96K | Jan 02 | View |
| Dec 05, 2013 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | -833.00 | $286.78 | -$238.89K | SELL | -5.74% | 13.67K | Dec 03 - Dec 04 | View |
| Dec 02, 2013 | Lynn Schenk | DIRECTOR | -1.00K | $291.71 | -$291.71K | SELL | -11.87% | 7.42K | Dec 02 | View |
| Nov 25, 2013 | Raymond Pawlicki | SVP, CHIEF INFORMATION OFFICER | 0.00 | $168.97 | -$952.20K | SELL-OPTIONS | 0.00% | 8.71K | Nov 22 | View |
| Nov 05, 2013 | Lynn Schenk | DIRECTOR | -1.00K | $245.00 | -$245.00K | SELL | -10.61% | 8.43K | Nov 01 | View |
| Nov 05, 2013 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.24K | $245.57 | -$549.83K | SELL | -4.80% | 44.42K | Nov 01 | View |
| Oct 23, 2013 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | 0.00 | $155.33 | -$2.85M | SELL-OPTIONS | 0.00% | 14.50K | Oct 22 | View |
| Oct 02, 2013 | Lynn Schenk | DIRECTOR | -1.00K | $242.85 | -$242.85K | SELL | -9.59% | 9.43K | Oct 01 | View |
| Oct 02, 2013 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.24K | $242.85 | -$543.74K | SELL | -4.58% | 46.66K | Oct 01 | View |
| Oct 02, 2013 | Kenneth DiPietro | EVP HUMAN RESOURCES | -1.44K | $242.00 | -$348.48K | SELL | -100.00% | 0.00 | Sep 30 | View |
| Sep 19, 2013 | Paul Clancy | EXECUTIVE VP AND CFO | 0.00 | $147.32 | -$5.23M | SELL-OPTIONS | 0.00% | 7.09K | Sep 18 | View |
| Sep 18, 2013 | Paul J Clancy | EXECUTIVE VP AND CFO | 0.00 | $147.19 | -$18.04M | SELL-OPTIONS | 0.00% | 7.09K | Sep 16 | View |
| Sep 18, 2013 | Steven H Holtzman | EVP CORPORATE DEVELOPMENT | -3.50K | $238.98 | -$836.67K | SELL | -41.75% | 4.88K | Sep 17 | View |
| Sep 18, 2013 | Alfred Sandrock | GRP SVP, CHIEF MEDICAL OFFICER | 0.00 | $144.88 | -$1.87M | SELL-OPTIONS | 0.00% | 14.50K | Sep 16 | View |
| Sep 18, 2013 | Raymond Pawlicki | SVP, CHIEF INFORMATION OFFICER | 0.00 | $143.81 | -$753.76K | SELL-OPTIONS | 0.00% | 8.71K | Sep 16 | View |
| Sep 13, 2013 | Lynn Schenk | DIRECTOR | -900.00 | $235.25 | -$211.73K | SELL | -7.95% | 10.43K | Sep 11 | View |
| Sep 04, 2013 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.24K | $214.40 | -$480.04K | SELL | -4.38% | 48.90K | Sep 03 | View |
| Aug 28, 2013 | Douglas E Williams | EVP RESEARCH & DEVELOPMENT | -4.37K | $211.35 | -$923.17K | SELL | -48.86% | 4.57K | Aug 26 | View |
| Aug 02, 2013 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.24K | $218.82 | -$489.94K | SELL | -4.19% | 51.14K | Aug 01 | View |
| Jul 18, 2013 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.24K | $223.94 | -$501.40K | SELL | -4.03% | 53.38K | Jul 16 | View |
| Jun 17, 2013 | Alexander J Denner | DIRECTOR | -2.90K | $212.00 | -$614.80K | SELL | -31.44% | 6.33K | Jun 14 | View |
| Jun 13, 2013 | Stelios Papadopoulos | DIRECTOR | -715.00 | $219.62 | -$443.63K | SELL | -4.78% | 14.23K | Jun 11 - Jun 12 | View |
| Jun 13, 2013 | Brian S Posner | DIRECTOR | -715.00 | $219.62 | -$443.63K | SELL | -7.04% | 9.44K | Jun 11 - Jun 12 | View |
| Jun 11, 2013 | Lynn Schenk | DIRECTOR | -2.00K | $225.82 | -$451.63K | SELL | -16.64% | 10.02K | Jun 10 | View |
| Jun 04, 2013 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.60K | $234.16 | -$374.19K | SELL | -2.86% | 54.29K | Jun 03 | View |
| Jun 04, 2013 | Stephen Sherwin | DIRECTOR | 0.00 | $146.54 | -$2.22M | SELL-OPTIONS | 0.00% | 2.65K | Jun 03 | View |
| May 29, 2013 | Richard Mulligan | DIRECTOR | 0.00 | $147.06 | -$7.11M | SELL-OPTIONS | 0.00% | 2.02K | May 28 | View |
| May 29, 2013 | Alexander J Denner | DIRECTOR | 0.00 | $147.00 | -$7.11M | SELL-OPTIONS | 0.00% | 4.92K | May 28 | View |
| May 29, 2013 | Robert W Pangia | DIRECTOR | -5.90K | $237.23 | -$1.40M | SELL | -31.72% | 12.70K | May 28 | View |
| May 03, 2013 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.60K | $215.39 | -$344.19K | SELL | -2.78% | 55.89K | May 01 | View |
| May 01, 2013 | Paul Clancy | EXECUTIVE VP AND CFO | -23.61K | $222.75 | -$5.26M | SELL | -76.91% | 7.09K | Apr 29 - Apr 30 | View |
| Apr 02, 2013 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.60K | $193.66 | -$309.47K | SELL | -2.70% | 57.48K | Apr 01 | View |
| Mar 25, 2013 | Richard Mulligan | DIRECTOR | -2.90K | $176.88 | -$512.95K | SELL | -58.94% | 2.02K | Mar 22 | View |
| Mar 25, 2013 | Stephen A Sherwin | DIRECTOR | -1.50K | $176.88 | -$265.32K | SELL | -36.10% | 2.65K | Mar 22 | View |
| Mar 19, 2013 | Brian S Posner | DIRECTOR | -4.50K | $174.81 | -$786.64K | SELL | -30.72% | 10.15K | Mar 18 | View |
| Mar 13, 2013 | Richard Mulligan | DIRECTOR | -7.98K | $175.38 | -$1.40M | SELL | -61.86% | 4.92K | Mar 13 | View |
| Mar 12, 2013 | Stelios Papadopoulos | DIRECTOR | 0.00 | $115.35 | -$5.31M | SELL-OPTIONS | 0.00% | 14.95K | Mar 11 | View |
| Mar 04, 2013 | George Scangos | CHIEF EXECUTIVE OFFICER | -1.60K | $165.30 | -$264.15K | SELL | -2.63% | 59.08K | Mar 01 | View |
| Feb 14, 2013 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.60K | $163.39 | -$261.10K | SELL | -2.57% | 60.68K | Feb 13 | View |
| Feb 07, 2013 | Robert W Pangia | DIRECTOR | 0.00 | $115.92 | -$248.15K | SELL-OPTIONS | 0.00% | 18.60K | Feb 06 | View |
| Feb 07, 2013 | Raymond Pawlicki | SVP, CHIEF INFORMATION OFFICER | 0.00 | $107.60 | -$1.16M | SELL-OPTIONS | 0.00% | 7.65K | Feb 06 | View |
| Dec 28, 2012 | Alexander J Denner | DIRECTOR | -7.98K | $148.62 | -$1.19M | SELL | -61.86% | 4.92K | Dec 26 - Dec 27 | View |
| Nov 02, 2012 | George Scangos | CHIEF EXECUTIVE OFFICER | -2.47K | $139.42 | -$344.64K | SELL | -4.57% | 51.67K | Nov 01 | View |
| Oct 02, 2012 | George A Scangos | CHIEF EXECUTIVE OFFICER | -3.65K | $149.16 | -$545.03K | SELL | -6.32% | 54.14K | Oct 01 | View |
| Sep 18, 2012 | Robert W Pangia | DIRECTOR | 0.00 | $110.65 | -$443.55K | SELL-OPTIONS | 0.00% | 18.60K | Sep 17 | View |
| Sep 10, 2012 | Robert W Pangia | DIRECTOR | 0.00 | $108.15 | -$418.55K | SELL-OPTIONS | 0.00% | 18.60K | Sep 06 | View |
| Sep 05, 2012 | Stephen A Sherwin | DIRECTOR | -2.00K | $145.90 | -$291.80K | SELL | -32.49% | 4.16K | Sep 04 | View |
| Sep 05, 2012 | George A Scangos | CHIEF EXECUTIVE OFFICER | -3.65K | $145.90 | -$533.12K | SELL | -5.95% | 57.80K | Sep 04 | View |
| Aug 03, 2012 | Susan H Alexander | EVP, GENERAL COUNSEL | -1.17K | $142.99 | -$166.58K | SELL | -11.44% | 9.02K | Aug 02 | View |
| Aug 02, 2012 | George Scangos | CHIEF EXECUTIVE OFFICER | -3.65K | $146.30 | -$534.73K | SELL | -5.61% | 61.45K | Aug 01 | View |
| Jul 30, 2012 | Susan H Alexander | EVP, GENERAL COUNSEL | 0.00 | $103.52 | -$5.40M | SELL-OPTIONS | 0.00% | 10.19K | Jul 27 | View |
| Jul 18, 2012 | George A Scangos | CHIEF EXECUTIVE OFFICER | -2.47K | $146.04 | -$361.01K | SELL | -3.66% | 65.11K | Jul 17 | View |
| Jul 03, 2012 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.18K | $143.50 | -$169.76K | SELL | -1.82% | 63.92K | Jul 02 | View |
| Jun 21, 2012 | Raymond Pawlicki | SVP, CHIEF INFORMATION OFFICER | 0.00 | $96.30 | -$934.10K | SELL-OPTIONS | 0.00% | 7.65K | Jun 19 | View |
| Jun 18, 2012 | Susan H Alexander | EVP, GENERAL COUNSEL | 0.00 | $93.93 | -$4.59M | SELL-OPTIONS | 0.00% | 10.19K | Jun 15 | View |
| Jun 18, 2012 | Robert W Pangia | DIRECTOR | 0.00 | $88.47 | -$515.30K | SELL-OPTIONS | 0.00% | 18.60K | Jun 15 | View |
| Jun 11, 2012 | Brian S Posner | DIRECTOR | 0.00 | $103.19 | -$159.05K | SELL-OPTIONS | 0.00% | 12.63K | Jun 07 | View |
| Jun 05, 2012 | Robert W Pangia | DIRECTOR | 0.00 | $83.47 | -$465.30K | SELL-OPTIONS | 0.00% | 16.58K | Jun 04 | View |
| Jun 05, 2012 | Stephen A Sherwin | DIRECTOR | -2.50K | $126.45 | -$316.13K | SELL | -37.68% | 4.13K | Jun 04 | View |
| Jun 05, 2012 | Brian S Posner | DIRECTOR | 0.00 | $98.91 | -$132.17K | SELL-OPTIONS | 0.00% | 12.63K | Jun 04 | View |
| Jun 05, 2012 | Raymond Pawlicki | SVP, CHIEF INFORMATION OFFICER | -1.07K | $126.45 | -$135.05K | SELL | -12.25% | 7.65K | Jun 04 | View |
| Jun 04, 2012 | George A Scangos | CHIEF EXECUTIVE OFFICER | -1.18K | $128.63 | -$152.17K | SELL | -1.78% | 65.10K | Jun 01 | View |
| May 03, 2012 | Lynn Schenk | DIRECTOR | -8.48K | $94.22 | -$1.63M | SELL | -54.43% | 7.10K | May 02 | View |
| May 03, 2012 | Susan H Alexander | EVP, GENERAL COUNSEL | 0.00 | $89.86 | -$1.81M | SELL-OPTIONS | 0.00% | 10.19K | May 02 | View |
| Apr 26, 2012 | Susan H Alexander | EVP, GENERAL COUNSEL | 0.00 | $87.36 | -$1.43M | SELL-OPTIONS | 0.00% | 10.19K | Apr 25 | View |
| Apr 06, 2012 | Susan H Alexander | EVP, GENERAL COUNSEL | 0.00 | $87.36 | -$275.93K | SELL-OPTIONS | 0.00% | 10.19K | Apr 04 | View |
| Mar 12, 2012 | Robert W Pangia | DIRECTOR | 0.00 | $77.60 | -$635.95K | SELL-OPTIONS | 0.00% | 16.58K | Mar 08 | View |
| Mar 01, 2012 | Robert E Gagnon | VICE PRESIDENT, FINANCE | -1.55K | $115.25 | -$178.87K | SELL | -27.96% | 4.00K | Feb 28 - Feb 29 | View |
| Feb 28, 2012 | Susan H Alexander | EVP, GENERAL COUNSEL | -4.25K | $115.43 | -$491.15K | SELL | -29.47% | 10.19K | Feb 27 | View |
| Feb 27, 2012 | Susan H Alexander | EVP, GENERAL COUNSEL | -2.34K | $116.16 | -$715.44K | SELL | -13.93% | 14.44K | Feb 23 - Feb 24 | View |
| Feb 27, 2012 | Robert E Gagnon | VICE PRESIDENT, FINANCE | 501.00 | $82.80 | -$153.59K | SELL-OPTIONS | 9.92% | 5.55K | Feb 23 - Feb 24 | View |
| Feb 16, 2012 | Stuart A Kingsley | EVP, GLOBAL COMM. OPERATIONS | -1.25K | $118.61 | -$147.91K | SELL | -100.00% | 0.00 | Feb 14 | View |
| Feb 16, 2012 | Robert E Gagnon | VICE PRESIDENT, FINANCE | -560.00 | $118.61 | -$66.42K | SELL | -9.98% | 5.05K | Feb 14 | View |
| Feb 14, 2012 | Susan H Alexander | EVP, GENERAL COUNSEL | -2.84K | $118.01 | -$335.38K | SELL | -14.49% | 16.78K | Feb 13 | View |
| Feb 08, 2012 | Stuart A Kingsley | EVP, GLOBAL COMM. OPERATIONS | -3.11K | $121.03 | -$376.40K | SELL | -100.00% | 0.00 | Feb 06 | View |
| Feb 03, 2012 | Paul J Clancy | EXECUTIVE VP AND CFO | 0.00 | $86.47 | -$1.43M | SELL-OPTIONS | 0.00% | 21.17K | Feb 01 | View |
| Feb 03, 2012 | Nancy Leaming | DIRECTOR | 0.00 | $89.59 | -$346.73K | SELL-OPTIONS | 0.00% | 6.33K | Feb 01 | View |
| Jan 24, 2012 | Nancy Leaming | DIRECTOR | 0.00 | $86.98 | -$186.09K | SELL-OPTIONS | 0.00% | 6.33K | Jan 20 | View |
| Jan 09, 2012 | Nancy Leaming | DIRECTOR | 0.00 | $85.98 | -$180.09K | SELL-OPTIONS | 0.00% | 6.33K | Jan 06 | View |
| Jan 09, 2012 | Eric K Rowinsky | DIRECTOR | 0.00 | $87.91 | -$729.89K | SELL-OPTIONS | 0.00% | 9.13K | Jan 06 | View |
| Jan 04, 2012 | Nancy Leaming | DIRECTOR | 0.00 | $84.98 | -$232.12K | SELL-OPTIONS | 0.00% | 6.33K | Jan 03 | View |
| Jan 04, 2012 | Paul J Clancy | EXECUTIVE VP AND CFO | -20.24K | $112.35 | -$2.27M | SELL | -48.88% | 21.17K | Jan 03 | View |
| Dec 20, 2011 | Stephen A Sherwin | DIRECTOR | -2.50K | $110.88 | -$277.20K | SELL | -27.37% | 6.63K | Dec 19 | View |
| Dec 08, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -795.00 | $112.31 | -$89.29K | SELL | -13.60% | 5.05K | Dec 06 | View |
| Nov 14, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -796.00 | $112.04 | -$89.18K | SELL | -11.35% | 6.22K | Nov 09 | View |
| Nov 03, 2011 | John Cox | EVP PHARMACEUTICAL OPER & TECH | 0.00 | $93.62 | -$90.26K | SELL-OPTIONS | 0.00% | 9.59K | Nov 01 | View |
| Oct 07, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -252.00 | $97.66 | -$24.61K | SELL | -3.30% | 7.38K | Oct 05 | View |
| Oct 04, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -118.00 | $71.11 | -$44.41K | SELL | -1.52% | 7.63K | Oct 01 - Oct 03 | View |
| Sep 29, 2011 | William Young | DIRECTOR | 0.00 | $73.76 | -$1.49M | SELL-OPTIONS | 0.00% | 26.86K | Sep 27 | View |
| Sep 19, 2011 | Nancy Leaming | DIRECTOR | -3.08K | $100.00 | -$308.50K | SELL | -32.75% | 6.33K | Sep 16 | View |
| Sep 02, 2011 | William Young | DIRECTOR | 0.00 | $70.84 | -$1.69M | SELL-OPTIONS | 0.00% | 26.86K | Sep 01 | View |
| Aug 31, 2011 | Brian S Posner | DIRECTOR | 0.00 | $81.95 | -$317.19K | SELL-OPTIONS | 0.00% | 12.63K | Aug 29 | View |
| Aug 31, 2011 | William Young | DIRECTOR | 0.00 | $80.36 | -$244.28K | SELL-OPTIONS | 0.00% | 26.86K | Aug 29 | View |
| Aug 03, 2011 | Susan H Alexander | EVP, GENERAL COUNSEL | -2.00K | $102.40 | -$204.80K | SELL | -10.55% | 16.96K | Aug 01 - Aug 02 | View |
| Jul 21, 2011 | George A Scangos | CHIEF EXECUTIVE OFFICER | -12.35K | $106.51 | -$1.32M | SELL | -18.48% | 54.46K | Jul 20 | View |
| Jul 01, 2011 | Francesco Granata | EVP GLOBAL COMMERCIAL OPERATIO | -2.90K | $107.52 | -$311.92K | SELL | -100.00% | 0.00 | Jul 01 | View |
| Jun 14, 2011 | Nancy Leaming | DIRECTOR | -2.30K | $92.62 | -$213.02K | SELL | -19.62% | 9.42K | Jun 14 | View |
| May 27, 2011 | Brian S Posner | DIRECTOR | 0.00 | $80.67 | -$697.18K | SELL-OPTIONS | 0.00% | 9.73K | May 25 | View |
| May 27, 2011 | Nancy Leaming | DIRECTOR | 0.00 | $74.28 | -$1.25M | SELL-OPTIONS | 0.00% | 8.82K | May 26 | View |
| May 27, 2011 | Robert W Pangia | DIRECTOR | 0.00 | $74.99 | -$543.45K | SELL-OPTIONS | 0.00% | 14.08K | May 26 | View |
| May 09, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -967.00 | $96.13 | -$92.96K | SELL | -11.09% | 7.75K | May 06 | View |
| May 04, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -665.00 | $97.35 | -$64.74K | SELL | -7.09% | 8.72K | May 03 - May 04 | View |
| May 03, 2011 | Susan H Alexander | EVP, GENERAL COUNSEL | -20.99K | $97.20 | -$2.04M | SELL | -52.54% | 18.96K | May 02 | View |
| Apr 29, 2011 | Paul J Clancy | EXECUTIVE VP AND CFO | -4.95K | $70.05 | -$1.34M | SELL | -10.49% | 42.25K | Apr 28 | View |
| Apr 25, 2011 | John Cox | EVP PHARMACEUTICAL OPER & TECH | 0.00 | $86.44 | -$118.02K | SELL-OPTIONS | 0.00% | 10.35K | Apr 21 | View |
| Apr 21, 2011 | Lynn Schenk | DIRECTOR | 0.00 | $73.53 | -$871.51K | SELL-OPTIONS | 0.00% | 15.58K | Apr 20 | View |
| Apr 15, 2011 | John Cox | EVP PHARMACEUTICAL OPER & TECH | 0.00 | $68.37 | -$843.07K | SELL-OPTIONS | 0.00% | 10.35K | Apr 13 | View |
| Apr 13, 2011 | John Cox | EVP PHARMACEUTICAL OPER & TECH | 0.00 | $62.96 | -$207.55K | SELL-OPTIONS | 0.00% | 10.35K | Apr 11 | View |
| Apr 01, 2011 | John Cox | EVP PHARMACEUTICAL OPER & TECH | 0.00 | $58.25 | -$83.78K | SELL-OPTIONS | 0.00% | 9.82K | Mar 31 | View |
| Mar 03, 2011 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -7.51K | $59.54 | -$645.11K | SELL | -41.33% | 10.66K | Mar 01 - Mar 02 | View |
| Mar 03, 2011 | John Cox | EVP PHARMACEUTICAL OPER & TECH | -4.04K | $70.10 | -$283.26K | SELL | -29.16% | 9.82K | Mar 02 | View |
| Mar 03, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -1.40K | $70.02 | -$98.16K | SELL | -12.88% | 9.49K | Mar 02 | View |
| Feb 25, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | 686.00 | $58.29 | -$39.64K | SELL-OPTIONS | 6.51% | 11.22K | Feb 23 - Feb 24 | View |
| Feb 25, 2011 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 3.43K | $58.65 | -$290.39K | SELL-OPTIONS | 20.31% | 20.33K | Feb 23 - Feb 25 | View |
| Feb 18, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -732.00 | $67.10 | -$49.12K | SELL | -6.50% | 10.54K | Feb 17 | View |
| Feb 18, 2011 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -3.19K | $67.08 | -$214.24K | SELL | -15.90% | 16.90K | Feb 17 | View |
| Feb 18, 2011 | John Cox | EVP PHARMACEUTICAL OPER & TECH | -1.84K | $67.08 | -$123.62K | SELL | -11.93% | 13.60K | Feb 17 | View |
| Jan 24, 2011 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 0.00 | $59.14 | -$118.56K | SELL-OPTIONS | 0.00% | 21.58K | Jan 20 | View |
| Jan 05, 2011 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -796.00 | $56.32 | -$141.28K | SELL | -6.86% | 10.81K | Jan 04 | View |
| Jan 03, 2011 | Lynn Schenk | DIRECTOR | 0.00 | $63.02 | -$113.24K | SELL-OPTIONS | 0.00% | 15.58K | Dec 30 | View |
| Dec 21, 2010 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 0.00 | $58.76 | -$367.41K | SELL-OPTIONS | 0.00% | 21.58K | Dec 17 | View |
| Dec 07, 2010 | Robert E Gagnon | CHIEF ACCT OFFICER VP & CONTR | -796.00 | $66.53 | -$52.96K | SELL | -6.42% | 11.61K | Dec 06 | View |
| Dec 07, 2010 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 0.00 | $55.72 | -$688.80K | SELL-OPTIONS | 0.00% | 21.58K | Dec 03 - Dec 07 | View |
| Nov 10, 2010 | John Cox | EVP PHARMACEUTICAL OPER & TECH | -773.00 | $62.87 | -$48.60K | SELL | -4.51% | 16.36K | Nov 09 | View |
| Nov 03, 2010 | John Cox | EVP PHARMACEUTICAL OPER & TECH | -1.13K | $62.88 | -$70.75K | SELL | -6.16% | 17.13K | Nov 01 - Nov 02 | View |
| Oct 29, 2010 | Robert W Pangia | DIRECTOR | 0.00 | $61.63 | -$71.25K | SELL-OPTIONS | 0.00% | 14.08K | Oct 28 | View |
| Oct 29, 2010 | John Cox | EVP PHARMACEUTICAL OPER & TECH | 0.00 | $48.48 | -$200.31K | SELL-OPTIONS | 0.00% | 18.25K | Oct 28 | View |
| Aug 17, 2010 | Caroline Dorsa | DIRECTOR | 177.00 | $56.41 | $9.98K | BUY | 2.19% | 8.24K | Aug 13 | View |
| Aug 03, 2010 | Michael F MacLean | SVP, CHIEF ACCOUNTING OFFICER | -9.54K | $56.85 | -$542.46K | SELL | -45.06% | 11.63K | Aug 02 | View |
| Aug 03, 2010 | Caroline Dorsa | DIRECTOR | 183.00 | $54.57 | $9.99K | BUY | 2.32% | 8.07K | Jul 30 | View |
| Jul 19, 2010 | Caroline Dorsa | DIRECTOR | 185.00 | $53.71 | $9.94K | BUY | 2.40% | 7.88K | Jul 16 | View |
| Jul 01, 2010 | Caroline Dorsa | DIRECTOR | 205.00 | $48.63 | $9.97K | BUY | 2.74% | 7.70K | Jun 30 | View |
| Jun 21, 2010 | Caroline Dorsa | DIRECTOR | 203.00 | $49.15 | $9.98K | BUY | 2.78% | 7.49K | Jun 18 | View |
| Jun 10, 2010 | Nancy Leaming | DIRECTOR | 4.83K | $47.62 | -$42.86K | GRANT | 121.33% | 8.82K | Jun 08 - Jun 09 | View |
| Jun 10, 2010 | Bruce Ross | DIRECTOR | -2.00K | $47.62 | -$95.24K | SELL | -16.81% | 9.90K | Jun 08 | View |
| Jun 01, 2010 | Caroline Dorsa | DIRECTOR | 208.00 | $48.01 | $9.99K | BUY | 15.44% | 1.55K | May 28 | View |
| May 17, 2010 | Caroline Dorsa | DIRECTOR | 195.00 | $51.19 | $9.98K | BUY | 16.93% | 1.35K | May 14 | View |
| May 03, 2010 | Caroline Dorsa | DIRECTOR | 187.00 | $53.38 | $9.98K | BUY | 19.38% | 1.15K | Apr 30 | View |
| Apr 26, 2010 | Robert A Hamm | CHIEF OPERATING OFFICER | -5.67K | $52.19 | -$295.83K | SELL | -17.24% | 27.21K | Apr 23 | View |
| Mar 23, 2010 | James C Mullen | CEO & PRESIDENT | 0.00 | $55.42 | -$4.01M | SELL-OPTIONS | 0.00% | 206.15K | Mar 19 - Mar 22 | View |
| Mar 23, 2010 | Michael F MacLean | SVP, CHIEF ACCOUNTING OFFICER | -4.08K | $60.00 | -$245.10K | SELL | -16.74% | 20.31K | Mar 19 | View |
| Mar 04, 2010 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -4.25K | $57.33 | -$243.95K | SELL | -16.82% | 21.04K | Mar 03 | View |
| Feb 19, 2010 | Robert A Hamm | CHIEF OPERATING OFFICER | -6.58K | $56.16 | -$369.56K | SELL | -22.29% | 22.95K | Feb 18 | View |
| Feb 19, 2010 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -6.55K | $56.16 | -$367.93K | SELL | -26.72% | 17.97K | Feb 18 | View |
| Jan 19, 2010 | Michael F MacLean | SVP, CHIEF ACCOUNTING OFFICER | -1.39K | $55.00 | -$76.39K | SELL | -5.63% | 23.26K | Jan 19 | View |
| Dec 24, 2009 | Robert W Pangia | DIRECTOR | 0.00 | $41.62 | -$315.97K | SELL-OPTIONS | 0.00% | 8.35K | Dec 24 | View |
| Dec 18, 2009 | James C Mullen | CEO & PRESIDENT | -147.04K | $50.18 | -$7.38M | SELL | -43.98% | 187.32K | Dec 16 | View |
| Nov 05, 2009 | Robert A Hamm | CHIEF OPERATING OFFICER | -2.85K | $42.81 | -$122.17K | SELL | -8.04% | 32.63K | Nov 04 | View |
| Sep 30, 2009 | Robert W Pangia | DIRECTOR | 0.00 | $41.54 | -$313.75K | SELL-OPTIONS | 0.00% | 8.35K | Sep 29 | View |
| Jun 25, 2009 | Bruce Ross | DIRECTOR | -1.70K | $48.53 | -$82.50K | SELL | -12.50% | 11.90K | Jun 24 | View |
| Jun 25, 2009 | Nancy Leaming | DIRECTOR | -820.00 | $48.52 | -$39.79K | SELL | -17.07% | 3.98K | Jun 24 | View |
| Jun 24, 2009 | Robert A. Hamm | CHIEF OPERATING OFFICER | -3.19K | $50.07 | -$159.91K | SELL | -7.84% | 37.53K | Jun 22 | View |
| Apr 09, 2009 | Cecil B Pickett | PRESIDENT, R & D | -17.40K | $54.50 | -$948.19K | SELL | -14.98% | 98.74K | Apr 08 | View |
| Feb 20, 2009 | Robert A Hamm | EVP, PHARMA. OPER. & TECH. | -3.41K | $50.90 | -$173.67K | SELL | -10.98% | 27.66K | Feb 19 | View |
| Feb 20, 2009 | John M. Dunn | EVP, NEW VENTURES | -3.21K | $50.90 | -$163.30K | SELL | -14.63% | 18.71K | Feb 19 | View |
| Feb 20, 2009 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -6.61K | $50.93 | -$336.45K | SELL | -27.03% | 17.83K | Feb 19 | View |
| Feb 20, 2009 | Hans Peter Hasler | CHIEF OPERATING OFFICER | -11.69K | $50.94 | -$595.67K | SELL | -30.33% | 26.86K | Feb 19 | View |
| Feb 13, 2009 | Hans Peter Hasler | CHIEF OPERATING OFFICER | -5.13K | $50.77 | -$260.70K | SELL | -10.13% | 45.57K | Feb 11 | View |
| Feb 13, 2009 | John M. Dunn | EVP, NEW VENTURES | -2.26K | $50.81 | -$114.73K | SELL | -8.30% | 24.96K | Feb 11 | View |
| Feb 13, 2009 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -5.40K | $50.76 | -$274.09K | SELL | -16.41% | 27.51K | Feb 11 | View |
| Feb 13, 2009 | Robert A. Hamm | EVP, PHARMA. OPER. & TECH. | -3.67K | $50.76 | -$186.28K | SELL | -9.70% | 34.15K | Feb 11 | View |
| Feb 06, 2009 | Cecil B Pickett | PRESIDENT, R & D | -8.70K | $53.00 | -$460.99K | SELL | -7.49% | 107.36K | Feb 04 | View |
| Jan 13, 2009 | Nancy Leaming | DIRECTOR | -340.00 | $48.43 | -$16.47K | SELL | -11.72% | 2.56K | Jan 13 | View |
| Nov 07, 2008 | Hans Peter Hasler | CHIEF OPERATING OFFICER | -845.00 | $44.31 | -$37.45K | SELL | -1.82% | 45.57K | Nov 06 | View |
| Nov 07, 2008 | Robert A. Hamm | EVP, PHARMA. OPER. & TECH. | -2.85K | $44.57 | -$127.25K | SELL | -7.72% | 34.15K | Nov 06 | View |
| Oct 06, 2008 | Michael F MacLean | SVP, CHIEF ACCOUNTING OFFICER | -2.05K | $50.00 | -$102.35K | SELL | -8.55% | 21.89K | Oct 06 | View |
| Sep 29, 2008 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | -734.00 | $50.00 | -$36.70K | SELL | -3.12% | 22.78K | Sep 26 | View |
| Sep 23, 2008 | Paul J Clancy | EXECUTIVE VP AND CFO | -1.55K | $50.00 | -$77.65K | SELL | -3.74% | 40.00K | Sep 19 | View |
| Aug 11, 2008 | Paul J Clancy | EXECUTIVE VP AND CFO | -568.00 | $50.66 | -$28.78K | SELL | -1.31% | 42.67K | Aug 08 | View |
| Aug 01, 2008 | Michael F MacLean | SVP, CHIEF ACCOUNTING OFFICER | 0.00 | $60.27 | -$46.88K | SELL-OPTIONS | 0.00% | 24.89K | Jul 31 | View |
| Jul 24, 2008 | Cecil B Pickett | PRESIDENT, R & D | -28.16K | $70.50 | -$1.99M | SELL | -17.29% | 134.76K | Jul 22 - Jul 23 | View |
| Jul 24, 2008 | Michael F MacLean | SVP, CHIEF ACCOUNTING OFFICER | -682.00 | $70.00 | -$47.74K | SELL | -2.67% | 24.89K | Jul 22 | View |
| Jul 24, 2008 | Hans Peter Hasler | EVP, GLOBAL NEUROLOGY, INT'L | 0.00 | $59.31 | -$259.00K | SELL-OPTIONS | 0.00% | 46.47K | Jul 22 | View |
| Jul 24, 2008 | Robert Hamm | EVP, PHARMA. OPER. & TECH. | 0.00 | $61.14 | -$2.77M | SELL-OPTIONS | 0.00% | 39.05K | Jul 22 | View |
| Jul 24, 2008 | John M. Dunn | EVP, NEW VENTURES | 0.00 | $57.50 | -$181.58K | SELL-OPTIONS | 0.00% | 24.99K | Jul 22 | View |
| Jul 24, 2008 | Susan H Alexander | EVP, GENERAL COUNSEL | -2.00K | $70.00 | -$140.00K | SELL | -8.44% | 21.71K | Jul 22 | View |
| Jul 22, 2008 | John M. Dunn | EVP, NEW VENTURES | 0.00 | $2.21K | $27.77M | SELL-OPTIONS | 0.00% | 24.99K | Jul 21 | View |
| Jul 22, 2008 | Phillip A. Sharp | DIRECTOR | 0.00 | $51.71 | -$2.36M | SELL-OPTIONS | 0.00% | 468.03K | Jul 21 | View |
| Jul 16, 2008 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $61.70 | -$28.81K | SELL-OPTIONS | 0.00% | 21.91K | Jul 15 | View |
| Jul 10, 2008 | Faheem Hasnain | EVP, ONCOLOGY/RHEUMATOLOGY SBU | -6.66K | $53.97 | -$902.36K | SELL | -20.74% | 25.45K | Jul 09 | View |
| Jul 09, 2008 | Susan H Alexander | EVP, GENERAL COUNSEL | -8.60K | $60.00 | -$515.94K | SELL | -26.62% | 23.71K | Jul 08 | View |
| Jul 02, 2008 | Paul C. Clancy | CFO | -4.21K | $56.01 | -$235.68K | SELL | -10.09% | 37.50K | Jul 01 | View |
| Jun 04, 2008 | Bruce Ross | DIRECTOR | -1.84K | $61.52 | -$113.20K | SELL | -26.86% | 5.01K | Jun 04 | View |
| May 01, 2008 | Alan Glassberg | DIRECTOR | 0.00 | $46.37 | -$305.68K | SELL-OPTIONS | 0.00% | 3.55K | Apr 29 | View |
| Apr 17, 2008 | Robert A Hamm | EVP, PHARMA. OPER. & TECH. | -3.41K | $63.82 | -$217.80K | SELL | -8.04% | 39.05K | Apr 15 | View |
| Apr 17, 2008 | James C Mullen | CEO & PRESIDENT | 0.00 | $54.77 | -$260.61K | SELL-OPTIONS | 0.00% | 180.75K | Apr 15 | View |
| Apr 15, 2008 | James C Mullen | CEO & PRESIDENT | -56.17K | $54.90 | -$3.67M | SELL | -23.71% | 180.75K | Apr 11 - Apr 14 | View |
| Apr 15, 2008 | James C Mullen | CEO & PRESIDENT | -197.31K | $65.02 | -$12.83M | SELL | -45.44% | 236.92K | Apr 11 | View |
| Apr 15, 2008 | James C Mullen | CEO & PRESIDENT | -195.16K | $64.89 | -$12.66M | SELL | -31.01% | 434.24K | Apr 11 | View |
| Apr 15, 2008 | James C Mullen | CEO & PRESIDENT | -102.02K | $64.56 | -$6.59M | SELL | -13.95% | 629.40K | Apr 11 | View |
| Apr 15, 2008 | James C Mullen | CEO & PRESIDENT | -121.16K | $64.38 | -$7.80M | SELL | -14.21% | 731.42K | Apr 11 | View |
| Apr 15, 2008 | James C Mullen | CEO & PRESIDENT | 671.82K | $52.73 | $26.00M | SELL-OPTIONS | 371.68% | 852.58K | Apr 11 | View |
| Apr 15, 2008 | John M. Dunn | EVP, NEW VENTURES | -3.21K | $64.20 | -$206.20K | SELL | -12.07% | 23.40K | Apr 14 | View |
| Apr 10, 2008 | Phillip A. Sharp | DIRECTOR | -7.50K | $64.86 | -$486.47K | SELL | -1.58% | 465.98K | Apr 08 | View |
| Apr 10, 2008 | Phillip A. Sharp | DIRECTOR | -15.65K | $64.61 | -$1.01M | SELL | -3.20% | 473.48K | Apr 08 | View |
| Apr 10, 2008 | Phillip A. Sharp | DIRECTOR | 23.15K | $50.09 | -$1.43M | SELL-OPTIONS | 4.97% | 489.13K | Apr 08 | View |
| Apr 10, 2008 | Robert W Pangia | DIRECTOR | -11.00K | $64.75 | -$712.23K | SELL | -73.09% | 4.05K | Apr 08 | View |
| Apr 10, 2008 | Robert W Pangia | DIRECTOR | 11.00K | $36.05 | -$988.21K | SELL-OPTIONS | 271.60% | 15.05K | Apr 08 | View |
| Apr 10, 2008 | Hans Peter Hasler | EVP, GLOBAL NEUROLOGY, INT'L | -7.66K | $64.53 | -$494.49K | SELL | -15.41% | 42.07K | Apr 08 | View |
| Apr 10, 2008 | Hans Peter Hasler | EVP, GLOBAL NEUROLOGY, INT'L | -3.74K | $54.04 | -$584.95K | SELL | -6.99% | 49.73K | Apr 08 | View |
| Apr 10, 2008 | Faheem Hasnain | EVP, ONCOLOGY/RHEUMATOLOGY SBU | -6.42K | $64.47 | -$414.21K | SELL | -16.67% | 32.12K | Apr 08 | View |
| Apr 10, 2008 | Michael F MacLean | SVP, CHIEF ACCOUNTING OFFICER | -2.21K | $64.37 | -$142.51K | SELL | -7.97% | 25.58K | Apr 08 | View |
| Feb 22, 2008 | Paul J Clancy | CFO | -2.18K | $60.22 | -$131.46K | SELL | -4.87% | 42.66K | Feb 21 | View |
| Feb 20, 2008 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -3.34K | $63.20 | -$211.33K | SELL | -11.17% | 26.59K | Feb 19 | View |
| Feb 14, 2008 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 4.93K | $60.87 | -$335.00K | GRANT | 80.88% | 11.02K | Feb 12 | View |
| Feb 14, 2008 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -3.20K | $61.11 | -$195.56K | SELL | -16.37% | 16.35K | Feb 12 | View |
| Feb 14, 2008 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 10.18K | $55.11 | -$348.18K | SELL-OPTIONS | 108.54% | 19.55K | Feb 12 | View |
| Feb 14, 2008 | Robert A Hamm | EVP, PHARMA. OPER. & TECH. | 8.77K | $60.81 | -$320.21K | GRANT | 44.66% | 28.42K | Feb 12 | View |
| Feb 14, 2008 | John M. Dunn | EVP, NEW VENTURES | 6.38K | $60.79 | -$246.48K | GRANT | 67.69% | 15.79K | Feb 12 | View |
| Feb 14, 2008 | Paul J Clancy | CFO | 13.99K | $60.78 | -$103.33K | GRANT | 86.45% | 30.17K | Feb 12 | View |
| Feb 07, 2008 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 4.29K | $52.71 | -$329.36K | SELL-OPTIONS | 35.03% | 16.52K | Feb 06 | View |
| Feb 07, 2008 | Craig Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -4.40K | $61.69 | -$271.42K | SELL | -16.29% | 22.61K | Feb 06 | View |
| Feb 07, 2008 | Craig Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 9.01K | $52.58 | -$188.70K | SELL-OPTIONS | 50.03% | 27.01K | Feb 06 | View |
| Jan 03, 2008 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | -9.80K | $57.34 | -$561.91K | SELL | -34.14% | 18.91K | Dec 31 | View |
| Jan 03, 2008 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 9.80K | $50.32 | $65.68K | SELL-OPTIONS | 51.84% | 28.71K | Dec 31 | View |
| Jan 03, 2008 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $50.36 | -$94.24K | SELL-OPTIONS | 0.00% | 12.91K | Dec 31 | View |
| Oct 17, 2007 | Lynn Schenk | DIRECTOR | 0.00 | $59.01 | -$2.90M | SELL-OPTIONS | 0.00% | 5.55K | Oct 15 | View |
| Oct 17, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $73.89 | -$1.45M | SELL-OPTIONS | 0.00% | 12.91K | Oct 15 | View |
| Oct 17, 2007 | Thomas F Keller | DIRECTOR | 0.00 | $54.40 | -$571.32K | SELL-OPTIONS | 0.00% | 4.47K | Oct 15 | View |
| Oct 17, 2007 | Hans Peter Hasler | SVP, INTERNATIONAL | 0.00 | $67.62 | -$3.13M | SELL-OPTIONS | 0.00% | 28.70K | Oct 15 | View |
| Oct 17, 2007 | Burt A Adelman | EVP, PORTFOLIO STRATEGY | 0.00 | $73.78 | -$994.69K | SELL-OPTIONS | 0.00% | 20.78K | Oct 15 | View |
| Oct 17, 2007 | Craig Eric Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 0.00 | $74.78 | -$270.56K | SELL-OPTIONS | 0.00% | 18.91K | Oct 15 | View |
| Sep 07, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $61.17 | -$510.90K | SELL-OPTIONS | 0.00% | 12.91K | Sep 06 | View |
| Aug 31, 2007 | Burt A Adelman | EVP, PORTFOLIO STRATEGY | 0.00 | $56.53 | -$690.00K | SELL-OPTIONS | 0.00% | 20.78K | Aug 30 | View |
| Aug 31, 2007 | Hans Peter Hasler | SVP, INTERNATIONAL | 0.00 | $54.24 | -$204.50K | SELL-OPTIONS | 0.00% | 28.70K | Aug 30 | View |
| Aug 29, 2007 | Hans Peter Hasler | SVP, INTERNATIONAL | 0.00 | $53.50 | -$412.12K | SELL-OPTIONS | 0.00% | 28.70K | Aug 27 | View |
| Aug 29, 2007 | Burt A. Adleman | EVP, PORTFOLIO STRATEGY | 0.00 | $53.50 | -$175.00K | SELL-OPTIONS | 0.00% | 20.78K | Aug 27 | View |
| Aug 29, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $61.70 | -$86.44K | SELL-OPTIONS | 0.00% | 12.91K | Aug 27 | View |
| Aug 27, 2007 | Thomas F Keller | DIRECTOR | 0.00 | $44.40 | -$242.88K | SELL-OPTIONS | 0.00% | 4.47K | Aug 24 | View |
| Aug 27, 2007 | Bruce Ross | DIRECTOR | 0.00 | $49.47 | -$156.63K | SELL-OPTIONS | 0.00% | 6.85K | Aug 24 | View |
| Aug 21, 2007 | Burt A Adelman | EVP, PORTFOLIO STRATEGY | 0.00 | $52.96 | -$431.26K | SELL-OPTIONS | 0.00% | 20.78K | Aug 17 | View |
| Aug 16, 2007 | Bruce Ross | DIRECTOR | 0.00 | $48.47 | -$144.13K | SELL-OPTIONS | 0.00% | 6.85K | Aug 15 | View |
| Aug 15, 2007 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 0.00 | $52.91 | -$803.27K | SELL-OPTIONS | 0.00% | 18.91K | Aug 14 | View |
| Jul 27, 2007 | Hans Peter Hasler | SVP, INTERNATIONAL | 0.00 | $47.45 | -$690.00K | SELL-OPTIONS | 0.00% | 28.70K | Jul 25 | View |
| Jul 27, 2007 | Bruce Ross | DIRECTOR | 0.00 | $46.17 | -$118.30K | SELL-OPTIONS | 0.00% | 6.85K | Jul 25 | View |
| Jul 27, 2007 | John M. Dunn | EVP, NEW VENTURES | 0.00 | $50.63 | -$285.00K | SELL-OPTIONS | 0.00% | 17.63K | Jul 25 | View |
| Jul 27, 2007 | Michael Kowolenko | SVP, PHARM OPS & TECHNOLOGY | 0.00 | $50.07 | -$325.31K | SELL-OPTIONS | 0.00% | 18.12K | Jul 25 | View |
| Jul 27, 2007 | Burt A Adelman | EVP, PORTFOLIO STRATEGY | 0.00 | $53.60 | -$1.64M | SELL-OPTIONS | 0.00% | 20.78K | Jul 25 - Jul 26 | View |
| Jul 25, 2007 | Bruce Ross | DIRECTOR | 0.00 | $45.17 | -$108.30K | SELL-OPTIONS | 0.00% | 6.85K | Jul 24 | View |
| Jul 13, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $45.10 | -$813.99K | SELL-OPTIONS | 0.00% | 12.91K | Jul 12 | View |
| Jul 13, 2007 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 0.00 | $48.92 | -$1.48M | SELL-OPTIONS | 0.00% | 18.91K | Jul 12 | View |
| Jul 10, 2007 | Craig E. Schneier | EVP, HR, PUBLIC AFFAIRS & COMM | 0.00 | $47.55 | -$417.87K | SELL-OPTIONS | 0.00% | 18.91K | Jul 09 | View |
| Jul 03, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | -733.00 | $44.67 | -$331.65K | SELL | -5.37% | 12.91K | Jul 02 - Jul 03 | View |
| Jul 03, 2007 | Burt A Adelman | EVP, PORTFOLIO STRATEGY | 0.00 | $49.24 | -$102.25K | SELL-OPTIONS | 0.00% | 20.78K | Jul 03 | View |
| Jun 28, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $48.62 | -$104.51K | SELL-OPTIONS | 0.00% | 13.64K | Jun 27 | View |
| Jun 28, 2007 | John M. Dunn | EVP, NEW VENTURES | 0.00 | $44.13 | -$269.12K | SELL-OPTIONS | 0.00% | 17.63K | Jun 27 | View |
| Jun 21, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | -5.83K | $51.75 | -$301.45K | SELL | -29.92% | 13.64K | Jun 20 | View |
| Jun 01, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $47.52 | -$55.23K | SELL-OPTIONS | 0.00% | 23.64K | May 30 | View |
| Jun 01, 2007 | Bruce Ross | DIRECTOR | 3.10K | $51.91 | -$77.86K | GRANT | 82.67% | 6.85K | May 31 | View |
| Jun 01, 2007 | Alan Glassberg | DIRECTOR | 2.30K | $41.31 | -$409.13K | SELL-OPTIONS | 184.00% | 3.55K | May 30 - May 31 | View |
| May 24, 2007 | Faheem Hasnain | SVP, ONCOLOGY SBU | -7.45K | $49.00 | -$364.85K | SELL | -22.33% | 25.90K | May 23 | View |
| May 24, 2007 | Mark Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $42.10 | -$137.92K | SELL-OPTIONS | 0.00% | 23.64K | May 23 | View |
| May 18, 2007 | Mark Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $40.84 | -$54.70K | SELL-OPTIONS | 0.00% | 23.64K | May 16 | View |
| Apr 25, 2007 | John M. Dunn | EVP, NEW VENTURES | -3.76K | $42.13 | -$386.81K | SELL | -17.58% | 17.63K | Apr 23 | View |
| Apr 25, 2007 | Mark Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $42.74 | -$424.56K | SELL-OPTIONS | 0.00% | 23.64K | Apr 23 | View |
| Apr 25, 2007 | Robert A Hamm | SVP, NEUROLOGY SBU | -3.73K | $47.34 | -$176.63K | SELL | -19.60% | 15.31K | Apr 23 | View |
| Apr 23, 2007 | John M. Dunn | EVP, NEW VENTURES | -7.52K | $46.02 | -$346.00K | SELL | -26.01% | 21.39K | Apr 20 | View |
| Apr 17, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $40.47 | -$51.00K | SELL-OPTIONS | 0.00% | 23.64K | Apr 16 | View |
| Mar 22, 2007 | Burt A Adelman | EVP, DEVELOPMENT | -6.63K | $44.48 | -$295.07K | SELL | -24.20% | 20.78K | Mar 20 | View |
| Mar 22, 2007 | Robert Hamm | SVP, IMMUNOLOGY BUSINESS UNIT | -5.08K | $44.48 | -$225.82K | SELL | -21.05% | 19.04K | Mar 20 | View |
| Mar 22, 2007 | Hans Peter Hasler | SVP, INTERNATIONAL | -5.91K | $44.48 | -$262.87K | SELL | -17.08% | 28.70K | Mar 20 | View |
| Mar 22, 2007 | Peter N Kellogg | EVP, FINANCE AND CFO | -7.25K | $44.48 | -$322.56K | SELL | -27.66% | 18.97K | Mar 20 | View |
| Mar 22, 2007 | Michael Kowolenko | SVP, PHARM OPS & TECHNOLOGY | -3.76K | $44.48 | -$167.06K | SELL | -17.29% | 17.97K | Mar 20 | View |
| Mar 22, 2007 | Craig Eric Schneier | EVP, HUMAN RESOURCES | -6.53K | $44.48 | -$290.27K | SELL | -26.42% | 18.17K | Mar 20 | View |
| Mar 22, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | -5.93K | $44.48 | -$263.72K | SELL | -20.56% | 22.91K | Mar 20 | View |
| Mar 16, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 5.93K | $39.72 | -$221.22K | SELL-OPTIONS | 25.88% | 28.84K | Mar 14 - Mar 15 | View |
| Feb 16, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | 0.00 | $42.77 | -$74.01K | SELL-OPTIONS | 0.00% | 22.91K | Feb 15 | View |
| Feb 15, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | -10.60K | $49.22 | -$521.44K | SELL | -31.62% | 22.91K | Feb 13 | View |
| Feb 15, 2007 | Craig Eric Schneier | EVP, HUMAN RESOURCES | -15.29K | $49.22 | -$752.51K | SELL | -45.69% | 18.17K | Feb 13 | View |
| Feb 15, 2007 | Michael Kowolenko | SVP, PHARM OPS & TECHNOLOGY | -8.83K | $49.22 | -$434.48K | SELL | -32.95% | 17.97K | Feb 13 | View |
| Feb 15, 2007 | Peter N Kellogg | EVP, FINANCE AND CFO | -10.20K | $49.22 | -$502.10K | SELL | -34.98% | 18.97K | Feb 13 | View |
| Feb 15, 2007 | Hans Peter Hasler | SVP, INTERNATIONAL | -5.19K | $49.22 | -$255.43K | SELL | -15.32% | 28.70K | Feb 13 | View |
| Feb 15, 2007 | Robert Hamm | SVP, IMMUNOLOGY BUSINESS UNIT | -6.19K | $49.22 | -$304.55K | SELL | -24.53% | 19.04K | Feb 13 | View |
| Feb 15, 2007 | John M. Dunn | EVP, NEW VENTURES | -2.33K | $49.22 | -$114.87K | SELL | -8.90% | 23.88K | Feb 13 | View |
| Feb 15, 2007 | Burt A Adelman | EVP, DEVELOPMENT | -11.87K | $49.22 | -$584.24K | SELL | -36.36% | 20.78K | Feb 13 | View |
| Jan 18, 2007 | Connie Matsui | EVP, CORP. STRATEGY AND COMM. | 0.00 | $29.14 | -$1.08M | SELL-OPTIONS | 0.00% | 63.34K | Jan 16 | View |
| Jan 18, 2007 | Mark C Wiggins | EVP CORP. AND BUS. DEV. | -1.35K | $43.05 | -$145.47K | SELL | -6.17% | 20.57K | Jan 16 | View |
| Nov 28, 2006 | James C Mullen | CEO & PRESIDENT | 0.00 | $43.54 | -$186.21K | SELL-OPTIONS | 0.00% | 94.25K | Nov 27 | View |
| Nov 27, 2006 | Bruce Ross | DIRECTOR | 0.00 | $41.54 | -$156.88K | SELL-OPTIONS | 0.00% | 0.00 | Nov 22 | View |
| Nov 21, 2006 | James Mullen | CEO & PRESIDENT | 0.00 | $43.63 | -$2.40M | SELL-OPTIONS | 0.00% | 94.25K | Nov 20 | View |
| Nov 20, 2006 | Bruce Ross | DIRECTOR | 0.00 | $40.54 | -$141.88K | SELL-OPTIONS | 0.00% | 0.00 | Nov 17 | View |
| Nov 17, 2006 | James Mullen | CEO & PRESIDENT | 0.00 | $42.94 | -$4.20M | SELL-OPTIONS | 0.00% | 94.25K | Nov 16 - Nov 17 | View |
| Nov 16, 2006 | John Dunn | EVP, NEW VENTURES | 0.00 | $42.19 | -$107.00K | SELL-OPTIONS | 0.00% | 26.13K | Nov 15 | View |
| Nov 02, 2006 | John Dunn | EVP, NEW VENTURES | 0.00 | $41.08 | -$149.63K | SELL-OPTIONS | 0.00% | 26.13K | Oct 31 | View |
| Nov 02, 2006 | Thomas Keller | DIRECTOR | 0.00 | $37.40 | -$73.14K | SELL-OPTIONS | 0.00% | 920.00 | Nov 01 | View |
| Oct 18, 2006 | Connie Matsui | EVP, CORP. STRATEGY AND COMM. | 0.00 | $26.61 | -$1.51M | SELL-OPTIONS | 0.00% | 63.34K | Oct 16 | View |
| Oct 03, 2006 | Fahemm Hasnain | SVP, ONCOLOGY SBU | -11.24K | $44.63 | -$501.77K | SELL | -51.02% | 10.79K | Oct 02 | View |
| Oct 03, 2006 | Alan Glassberg | DIRECTOR | 0.00 | $26.21 | -$483.96K | SELL-OPTIONS | 0.00% | 0.00 | Oct 02 | View |
| Sep 20, 2006 | Mark c Wiggins | EVP CORP. AND BUS. DEV. | -18.19K | $42.78 | -$777.96K | SELL | -45.34% | 21.92K | Sep 19 | View |
| Sep 20, 2006 | Craig E. Schneier | EVP, HUMAN RESOURCES | -20.18K | $42.78 | -$863.09K | SELL | -52.62% | 18.16K | Sep 19 | View |
| Sep 20, 2006 | Michael Kowolenko | SVP, PHARM OPS & TECHNOLOGY | -11.94K | $42.78 | -$510.90K | SELL | -57.30% | 8.90K | Sep 19 | View |
| Sep 20, 2006 | Peter N Kellogg | EVP, FINANCE AND CFO | -22.03K | $42.78 | -$942.53K | SELL | -56.32% | 17.09K | Sep 19 | View |
| Sep 20, 2006 | Burt A Adelman | EVP, DEVELOPMENT | -18.35K | $42.78 | -$784.89K | SELL | -100.00% | 0.00 | Sep 19 | View |
| Sep 20, 2006 | Robert Hamm | SVP, IMMUNOLOGY BUSINESS UNIT | -16.21K | $42.78 | -$693.31K | SELL | -63.06% | 9.49K | Sep 19 | View |
| Sep 05, 2006 | THOMAS KELLER | DIRECTOR | 0.00 | $29.88 | -$203.14K | SELL-OPTIONS | 0.00% | 920.00 | Sep 01 | View |
| Jul 27, 2006 | Alan Belzer | DIRECTOR | 0.00 | $28.08 | -$749.63K | SELL-OPTIONS | 0.00% | 46.00K | Jul 26 | View |
| Jul 26, 2006 | Alan Belzer | DIRECTOR | 0.00 | $28.18 | -$1.04M | SELL-OPTIONS | 0.00% | 46.00K | Jul 24 - Jul 25 | View |
| Jul 18, 2006 | Connie Matsui | EVP, CORP. STRATEGY AND COMM. | 0.00 | $25.19 | -$1.40M | SELL-OPTIONS | 0.00% | 53.11K | Jul 17 | View |
| May 02, 2006 | James C Mullen | CEO & PRESIDENT | 0.00 | $30.36 | -$257.19K | SELL-OPTIONS | 0.00% | 94.25K | Apr 28 | View |
| May 02, 2006 | Connie Matsui | EVP, CORP. STRATEGY AND COMM. | 0.00 | $26.44 | -$1.50M | SELL-OPTIONS | 0.00% | 137.59K | Apr 28 | View |
| May 02, 2006 | Mary L Good | DIRECTOR | 0.00 | $29.86 | -$307.60K | SELL-OPTIONS | 0.00% | 0.00 | Apr 28 | View |
| Apr 04, 2006 | Thomas F Keller | DIRECTOR | 0.00 | $31.06 | -$329.06K | SELL-OPTIONS | 0.00% | 7.82K | Mar 31 | View |
| Jan 05, 2006 | Burt A Adelman | EVP, DEVELOPMENT | 0.00 | $38.60 | -$1.43M | SELL-OPTIONS | 0.00% | 19.51K | Jan 03 | View |
| Jan 05, 2006 | Mark C Wiggins | EVP - BUSINESS DEVELOPMENT | 14.92K | $35.21 | $525.31K | s | 266.83% | 20.51K | Jan 03 | View |
| Dec 28, 2005 | Burt A Adelman | EVP, DEVELOPMENT | 0.00 | $30.77 | -$568.47K | SELL-OPTIONS | 0.00% | 8.01K | Dec 28 | View |
| Dec 20, 2005 | Connie Matsui | EVP, CORP. STRATEGY AND COMM. | 0.00 | $22.10 | -$1.12M | SELL-OPTIONS | 0.00% | 137.99K | Oct 12 | View |
| Oct 04, 2005 | Thomas F Keller | DIRECTOR | 7.05K | $26.97 | $28.91K | SELL-OPTIONS | 63.40% | 18.17K | Oct 01 | View |
| Oct 04, 2005 | Thomas F Keller | DIRECTOR | 3.30K | $27.22 | -$120.09K | SELL-OPTIONS | 18.16% | 21.47K | Oct 01 | View |
| Sep 30, 2005 | Burt A Adelman | EVP, DEVELOPMENT | 7.80K | $25.79 | -$162.06K | SELL-OPTIONS | 97.39% | 15.81K | Sep 28 | View |
| Sep 30, 2005 | Burt A Adelman | EVP, DEVELOPMENT | 10.20K | $25.87 | -$120.25K | SELL-OPTIONS | 55.71% | 28.51K | Sep 28 | View |
| Jul 13, 2005 | Connie Matsui | EVP, CORP. STRATEGY AND COMM. | -80.00K | $36.22 | -$2.90M | SELL | -46.80% | 90.95K | Jul 12 | View |
| Jun 30, 2005 | Burt A Adelman | EVP, DEVELOPMENT | 20.20K | $23.40 | $254.49K | SELL-OPTIONS | 347.74% | 26.01K | Jun 28 | View |
| Jun 30, 2005 | Burt A Adelman | EVP, DEVELOPMENT | 300.00 | $23.61 | -$428.43K | SELL-OPTIONS | 1.15% | 26.31K | Jun 28 | View |
| Feb 22, 2005 | Thomas J Bucknum | EVP AND GENERAL COUNSEL | 0.00 | $56.32 | -$1.94M | SELL-OPTIONS | 0.00% | 14.75K | Feb 18 | View |
| Feb 17, 2005 | William H Rastetter | EXECUTIVE CHAIRMAN | 0.00 | $35.54 | -$7.75M | SELL-OPTIONS | 0.00% | 50.68K | Feb 15 | View |
| Feb 15, 2005 | Robert W Pangia | DIRECTOR | 500.00 | $36.69 | -$951.66K | SELL-OPTIONS | 100.00% | 1.00K | Feb 14 | View |
| Feb 15, 2005 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $52.02 | -$102.02K | SELL-OPTIONS | 0.00% | 29.21K | Feb 14 | View |
| Feb 02, 2005 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $50.48 | -$91.18K | SELL-OPTIONS | 0.00% | 32.71K | Jan 31 | View |
| Jan 26, 2005 | James C Mullen | CEO & PRESIDENT | 0.00 | $39.74 | -$266.23K | SELL-OPTIONS | 0.00% | 102.93K | Jan 24 | View |
| Jan 20, 2005 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $51.71 | -$99.82K | SELL-OPTIONS | 0.00% | 36.21K | Jan 18 | View |
| Jan 20, 2005 | James C Mullen | CEO & PRESIDENT | 0.00 | $41.67 | -$287.44K | SELL-OPTIONS | 0.00% | 108.43K | Jan 18 | View |
| Jan 12, 2005 | James C Mullen | CEO & PRESIDENT | 0.00 | $40.99 | -$279.90K | SELL-OPTIONS | 0.00% | 113.93K | Jan 10 | View |
| Jan 04, 2005 | Burt A Adelman | EVP, DEVELOPMENT | 0.00 | $39.97 | -$1.11M | SELL-OPTIONS | 0.00% | 46.51K | Jan 03 | View |
| Jan 04, 2005 | James C Mullen | CEO & PRESIDENT | 0.00 | $41.43 | -$284.77K | SELL-OPTIONS | 0.00% | 119.43K | Jan 03 | View |
| Jan 04, 2005 | Mark C Wiggins | EVP - BUSINESS DEVELOPMENT | 0.00 | $51.02 | -$395.40K | SELL-OPTIONS | 0.00% | 80.29K | Jan 03 | View |
| Jan 04, 2005 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $52.15 | -$113.89K | SELL-OPTIONS | 0.00% | 39.71K | Jan 03 | View |
| Jan 04, 2005 | Mary L Good | DIRECTOR | 0.00 | $40.69 | -$262.10K | SELL-OPTIONS | 0.00% | 10.00K | Jan 03 | View |
| Jan 03, 2005 | Michael Gilman | EVP - RESEARCH | 0.00 | $56.23 | -$287.45K | SELL-OPTIONS | 0.00% | 36.18K | Dec 28 | View |
| Dec 28, 2004 | Burt A Adelman | EVP, DEVELOPMENT | 0.00 | $37.43 | -$699.07K | SELL-OPTIONS | 0.00% | 8.01K | Dec 27 | View |
| Dec 28, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $40.79 | -$277.80K | SELL-OPTIONS | 0.00% | 124.93K | Dec 27 | View |
| Dec 21, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $40.28 | -$272.14K | SELL-OPTIONS | 0.00% | 130.43K | Dec 20 | View |
| Dec 16, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $40.71 | -$273.66K | SELL-OPTIONS | 0.00% | 135.93K | Dec 13 | View |
| Dec 13, 2004 | Michael Gilman | EVP - RESEARCH | 0.00 | $52.97 | -$367.32K | SELL-OPTIONS | 0.00% | 28.70K | Dec 09 | View |
| Dec 13, 2004 | John M. Dunn | EVP, NEW VENTURES | 0.00 | $50.19 | -$148.15K | SELL-OPTIONS | 0.00% | 53.36K | Dec 09 | View |
| Dec 08, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $53.49 | -$86.94K | SELL-OPTIONS | 0.00% | 57.96K | Dec 06 | View |
| Dec 08, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $38.98 | -$242.86K | SELL-OPTIONS | 0.00% | 95.43K | Dec 06 | View |
| Dec 03, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $38.45 | -$43.10K | SELL-OPTIONS | 0.00% | 100.93K | Dec 02 | View |
| Dec 03, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $52.97 | -$80.90K | SELL-OPTIONS | 0.00% | 63.71K | Dec 01 | View |
| Dec 01, 2004 | Alan Glassberg | DIRECTOR | 0.00 | $32.92 | -$502.58K | SELL-OPTIONS | 0.00% | 13.14K | Nov 30 | View |
| Dec 01, 2004 | Thomas J Bucknum | EVP AND GENERAL COUNSEL | 0.00 | $36.88 | -$1.50M | SELL-OPTIONS | 0.00% | 9.00K | Nov 30 | View |
| Dec 01, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $37.80 | -$188.06K | SELL-OPTIONS | 0.00% | 101.93K | Nov 29 | View |
| Nov 23, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $37.81 | -$188.20K | SELL-OPTIONS | 0.00% | 106.43K | Nov 22 | View |
| Nov 23, 2004 | Bruce Ross | DIRECTOR | 0.00 | $43.50 | -$372.40K | SELL-OPTIONS | 0.00% | 15.00K | Nov 19 | View |
| Nov 19, 2004 | William R Rohn | CHIEF OPERATING OFFICER | -2.70K | $58.29 | -$157.39K | SELL | -3.05% | 85.76K | Nov 17 | View |
| Nov 19, 2004 | William R Rohn | CHIEF OPERATING OFFICER | 2.70K | $32.51 | -$3.68M | SELL-OPTIONS | 3.15% | 88.46K | Nov 17 | View |
| Nov 17, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $37.81 | -$188.20K | SELL-OPTIONS | 0.00% | 110.93K | Nov 15 | View |
| Nov 17, 2004 | Mark C Wiggins | EVP - BUSINESS DEVELOPMENT | -5.00K | $58.80 | -$294.00K | SELL | -14.72% | 28.98K | Nov 15 | View |
| Nov 09, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $39.04 | -$243.57K | SELL-OPTIONS | 0.00% | 115.43K | Nov 08 | View |
| Nov 09, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $53.68 | -$89.11K | SELL-OPTIONS | 0.00% | 69.46K | Nov 08 | View |
| Nov 09, 2004 | John M. Dunn | EVP, NEW VENTURES | -571.00 | $62.00 | -$35.40K | SELL | -4.59% | 11.88K | Nov 08 | View |
| Nov 04, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $38.45 | -$43.10K | SELL-OPTIONS | 0.00% | 120.93K | Nov 03 | View |
| Nov 02, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $37.46 | -$185.05K | SELL-OPTIONS | 0.00% | 121.93K | Nov 01 | View |
| Nov 01, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $38.45 | -$43.10K | SELL-OPTIONS | 0.00% | 126.43K | Oct 28 | View |
| Nov 01, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $52.97 | -$80.90K | SELL-OPTIONS | 0.00% | 75.21K | Oct 28 | View |
| Oct 26, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $36.42 | -$175.71K | SELL-OPTIONS | 0.00% | 127.43K | Oct 25 | View |
| Oct 20, 2004 | James C Mullen | CEO & PRESIDENT | -675.00 | $37.34 | -$195.39K | SELL | -0.51% | 131.93K | Oct 18 | View |
| Oct 13, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $52.98 | -$81.13K | SELL-OPTIONS | 0.00% | 81.21K | Oct 11 | View |
| Oct 13, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $37.72 | -$246.31K | SELL-OPTIONS | 0.00% | 136.43K | Oct 11 | View |
| Oct 06, 2004 | Mark C Wiggins | EVP - BUSINESS DEVELOPMENT | 0.00 | $48.85 | -$341.02K | SELL-OPTIONS | 0.00% | 79.00K | Aug 03 - Oct 04 | View |
| Oct 05, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $37.19 | -$280.01K | SELL-OPTIONS | 0.00% | 95.93K | Oct 04 | View |
| Oct 05, 2004 | Thomas F Keller | DIRECTOR | 0.00 | $38.08 | -$474.44K | SELL-OPTIONS | 0.00% | 28.52K | Oct 01 | View |
| Oct 05, 2004 | Mary L Good | DIRECTOR | 0.00 | $37.74 | -$232.60K | SELL-OPTIONS | 0.00% | 15.00K | Oct 01 | View |
| Sep 29, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $52.97 | -$80.90K | SELL-OPTIONS | 0.00% | 86.71K | Sep 27 | View |
| Sep 29, 2004 | Burt A Adelman | EVP, DEVELOPMENT | 0.00 | $34.44 | -$623.81K | SELL-OPTIONS | 0.00% | 20.60K | Sep 27 | View |
| Sep 29, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $35.66 | -$263.24K | SELL-OPTIONS | 0.00% | 101.43K | Sep 27 | View |
| Sep 21, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $36.92 | -$277.12K | SELL-OPTIONS | 0.00% | 106.93K | Sep 20 | View |
| Sep 15, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $53.84 | -$90.97K | SELL-OPTIONS | 0.00% | 92.46K | Sep 13 | View |
| Sep 15, 2004 | Michael Gilman | EVP - RESEARCH | 0.00 | $53.52 | -$538.80K | SELL-OPTIONS | 0.00% | 27.56K | Sep 13 | View |
| Sep 15, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $36.76 | -$275.35K | SELL-OPTIONS | 0.00% | 112.43K | Sep 13 | View |
| Sep 08, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $36.52 | -$272.63K | SELL-OPTIONS | 0.00% | 117.93K | Sep 07 | View |
| Sep 02, 2004 | William R Rohn | CHIEF OPERATING OFFICER | 0.00 | $32.73 | -$1.29M | SELL-OPTIONS | 0.00% | 160.76K | Aug 31 | View |
| Sep 01, 2004 | William R Rohn | CHIEF OPERATING OFFICER | 0.00 | $32.69 | -$2.59M | SELL-OPTIONS | 0.00% | 19.63K | Aug 30 | View |
| Aug 31, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $35.65 | -$263.15K | SELL-OPTIONS | 0.00% | 123.43K | Aug 30 | View |
| Aug 31, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $53.10 | -$82.50K | SELL-OPTIONS | 0.00% | 98.21K | Aug 30 | View |
| Aug 27, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $35.87 | -$48.27K | SELL-OPTIONS | 0.00% | 128.93K | Aug 25 | View |
| Aug 24, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $35.67 | -$215.46K | SELL-OPTIONS | 0.00% | 129.93K | Aug 23 | View |
| Aug 24, 2004 | Connie Matsui | EVP, CORP. STRATEGY AND COMM. | 0.00 | $32.98 | -$4.17M | SELL-OPTIONS | 0.00% | 178.27K | Aug 20 | View |
| Aug 19, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $35.87 | -$48.27K | SELL-OPTIONS | 0.00% | 134.43K | Aug 18 | View |
| Aug 19, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $52.99 | -$131.60K | SELL-OPTIONS | 0.00% | 103.96K | Aug 18 | View |
| Aug 18, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $35.08 | -$210.10K | SELL-OPTIONS | 0.00% | 135.43K | Aug 16 | View |
| Aug 11, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $33.82 | -$198.78K | SELL-OPTIONS | 0.00% | 139.93K | Aug 10 | View |
| Aug 05, 2004 | Alan Glassberg | DIRECTOR | 0.00 | $32.04 | -$783.72K | SELL-OPTIONS | 0.00% | 28.14K | Aug 04 | View |
| Aug 05, 2004 | Mark C Wiggins | EVP - BUSINESS DEVELOPMENT | -22.50K | $57.82 | -$1.30M | SELL | -39.84% | 33.98K | Aug 04 | View |
| Aug 04, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $52.97 | -$30.63K | SELL-OPTIONS | 0.00% | 113.28K | Aug 02 | View |
| Aug 04, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $35.17 | -$210.94K | SELL-OPTIONS | 0.00% | 144.43K | Aug 02 | View |
| Aug 03, 2004 | Mark C Wiggins | EVP - BUSINESS DEVELOPMENT | 0.00 | $41.88 | -$592.14K | SELL-OPTIONS | 0.00% | 22.79K | Jul 30 | View |
| Aug 02, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $35.79 | -$48.13K | SELL-OPTIONS | 0.00% | 148.93K | Jul 30 | View |
| Jul 27, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $32.58 | -$187.66K | SELL-OPTIONS | 0.00% | 149.93K | Jul 19 - Jul 26 | View |
| Jul 20, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $34.83 | -$207.87K | SELL-OPTIONS | 0.00% | 154.43K | Jul 19 | View |
| Jul 19, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $47.70 | -$71.78K | SELL-OPTIONS | 0.00% | 43.59K | Jul 19 | View |
| Jul 15, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $36.16 | -$268.70K | SELL-OPTIONS | 0.00% | 158.93K | Jul 13 | View |
| Jul 09, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $36.30 | -$288.65K | SELL-OPTIONS | 0.00% | 164.43K | Jul 06 | View |
| Jul 08, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $47.88 | -$73.03K | SELL-OPTIONS | 0.00% | 47.09K | Jul 06 | View |
| Jun 30, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $35.19 | -$306.69K | SELL-OPTIONS | 0.00% | 96.33K | Jun 29 | View |
| Jun 29, 2004 | Burt A Adelman | EVP, DEVELOPMENT | 0.00 | $36.34 | -$671.58K | SELL-OPTIONS | 0.00% | 33.19K | Jun 28 | View |
| Jun 28, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $33.70 | -$52.78K | SELL-OPTIONS | 0.00% | 101.83K | Jun 24 | View |
| Jun 23, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $32.42 | -$225.99K | SELL-OPTIONS | 0.00% | 102.83K | Jun 21 | View |
| Jun 21, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $47.87 | -$72.96K | SELL-OPTIONS | 0.00% | 50.59K | Jun 21 | View |
| Jun 15, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $33.66 | -$289.90K | SELL-OPTIONS | 0.00% | 107.33K | Jun 14 | View |
| Jun 08, 2004 | Craig Eric Schneier | EVP, HUMAN RESOURCES | 0.00 | $49.72 | -$95.06K | SELL-OPTIONS | 0.00% | 54.09K | Jun 07 | View |
| Jun 08, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $34.55 | -$299.66K | SELL-OPTIONS | 0.00% | 112.83K | Jun 07 | View |
| Jun 04, 2004 | William S. Rohn | CHIEF OPERATING OFFICER | -18.70K | $63.67 | -$1.19M | SELL | -12.43% | 131.70K | Jun 02 | View |
| Jun 04, 2004 | William S. Rohn | CHIEF OPERATING OFFICER | 18.70K | $35.52 | -$1.60M | GRANT | 14.20% | 150.40K | Jun 02 | View |
| Jun 02, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $34.66 | -$300.85K | SELL-OPTIONS | 0.00% | 118.33K | Jun 01 | View |
| May 26, 2004 | William Young | DIRECTOR | 0.00 | $39.39 | -$2.43M | SELL-OPTIONS | 0.00% | 0.00 | May 25 | View |
| May 26, 2004 | William H Rastetter | EXECUTIVE CHAIRMAN | 0.00 | $32.93 | -$1.72M | SELL-OPTIONS | 0.00% | 129.45K | May 24 | View |
| May 26, 2004 | James C Mullen | CEO & PRESIDENT | 0.00 | $34.31 | -$296.99K | SELL-OPTIONS | 0.00% | 123.83K | May 24 | View |
| May 26, 2004 | Mary L Good | DIRECTOR | 0.00 | $38.19 | -$687.59K | SELL-OPTIONS | 0.00% | 20.00K | May 24 - May 26 | View |
| May 26, 2004 | Thomas J Bucknum | EVP AND GENERAL COUNSEL | 0.00 | $37.78 | -$1.48M | SELL-OPTIONS | 0.00% | 24.50K | May 25 | View |
| May 26, 2004 | Alan Glassberg | DIRECTOR | 0.00 | $33.87 | -$590.21K | SELL-OPTIONS | 0.00% | 13.14K | May 26 | View |
| May 20, 2004 | Whilliam H. Rastetter | EXECUTIVE CHAIRMAN | 0.00 | $31.69 | -$1.42M | SELL-OPTIONS | 0.00% | 158.53K | May 19 | View |
| May 19, 2004 | Connie Matsui | EVP, CORP. STRATEGY AND COMM. | 0.00 | $32.98 | -$3.13M | SELL-OPTIONS | 0.00% | 258.27K | May 18 | View |
| May 19, 2004 | John M. Dunn | EVP, NEW VENTURES | 0.00 | $47.21 | -$355.25K | SELL-OPTIONS | 0.00% | 58.36K | May 18 | View |
| May 17, 2004 | Phillip A. Sharp | DIRECTOR | -294.10K | $58.76 | -$17.28M | SELL | -23.53% | 956.00K | May 14 | View |
| May 14, 2004 | Phillip A. Sharp | DIRECTOR | 0.00 | $34.87 | -$3.01M | SELL-OPTIONS | 0.00% | 772.10K | May 13 | View |
| May 06, 2004 | William H Rastetter | EXECUTIVE CHAIRMAN | 450.22K | $29.95 | -$6.96M | SELL-OPTIONS | 180.80% | 699.24K | May 04 | View |
| May 06, 2004 | Alan Glassberg | DIRECTOR | 0.00 | $31.53 | -$1.65M | SELL-OPTIONS | 0.00% | 8.14K | May 05 | View |
| May 06, 2004 | Burt A Adelman | EVP, DEVELOPMENT | 0.00 | $35.60 | -$453.70K | SELL-OPTIONS | 0.00% | 67.01K | May 05 | View |
| May 06, 2004 | Robert W Pangia | DIRECTOR | 1.00K | $32.47 | -$1.51M | SELL-OPTIONS | 6.15% | 17.25K | May 05 | View |
| May 05, 2004 | Phillip A. Sharp | DIRECTOR | -55.90K | $35.36 | -$4.38M | SELL | -3.49% | 1.54M | May 04 - May 05 | View |
| May 05, 2004 | Thomas J Bucknum | EVP AND GENERAL COUNSEL | 0.00 | $36.01 | -$1.58M | SELL-OPTIONS | 0.00% | 54.50K | May 04 | View |
| Apr 05, 2004 | thomas F Keller | DIRECTOR | 0.00 | $35.34 | -$417.79K | SELL-OPTIONS | 0.00% | 920.00 | Apr 01 | View |
| Apr 05, 2004 | Nabil Hanna | EVP DISCOVERY RESEARCH | 615.90 | $27.94 | -$5.73M | SELL-OPTIONS | 0.14% | 450.90K | Mar 31 - Apr 01 | View |
| Mar 31, 2004 | Burt A Adelman | EXECUTIVE VP DEVELOPMENT | 0.00 | $31.11 | -$560.58K | SELL-OPTIONS | 0.00% | 20.28K | Mar 29 | View |
| Mar 04, 2004 | William R Rohn | EXEC VP & COO | 0.00 | $31.71 | -$969.38K | SELL-OPTIONS | 0.00% | 397.01K | Mar 02 | View |
| Mar 04, 2004 | William R Rohn | EXEC VP & COO | 0.00 | $31.54 | -$1.30M | SELL-OPTIONS | 0.00% | 19.63K | Mar 02 | View |
| Mar 04, 2004 | William R Rohn | EXEC VP & COO | 0.00 | $30.89 | -$879.40K | SELL-OPTIONS | 0.00% | 19.63K | Mar 02 | View |
| Mar 04, 2004 | William R Rohn | EXEC VP & COO | 0.00 | $31.19 | -$2.95M | SELL-OPTIONS | 0.00% | 19.63K | Mar 02 | View |
| Feb 20, 2004 | William R Rohn | EXEC VP & COO | 0.00 | $29.05 | -$1.14M | SELL-OPTIONS | 0.00% | 397.01K | Feb 18 | View |
| Feb 20, 2004 | THOMAS KELLER | DIRECTOR | 0.00 | $33.48 | -$379.22K | SELL-OPTIONS | 0.00% | 920.00 | Feb 18 | View |
| Feb 18, 2004 | Lynn Schenk | DIRECTOR | -10.50K | $28.14 | -$5.69M | SELL | -100.00% | 0.00 | Feb 18 | View |
| Jan 23, 2004 | William Rohn | EXEC VP & COO | 0.00 | $25.60 | -$970.50K | SELL-OPTIONS | 0.00% | 377.39K | Jan 21 | View |
| Jan 09, 2004 | Nabil Hanna | EVP, RESEARCH | 0.00 | $20.75 | -$5.47M | SELL-OPTIONS | 0.00% | 433.63K | Jan 08 | View |
| Jan 07, 2004 | William Rohn | EXEC VP & COO | 0.00 | $23.09 | -$845.31K | SELL-OPTIONS | 0.00% | 377.39K | Jan 07 | View |
| Jan 05, 2004 | Nabil Hanna | EVP, RESEARCH | 0.00 | $18.75 | -$547.50K | SELL-OPTIONS | 0.00% | 433.63K | Jan 02 | View |
| Dec 08, 2003 | Burt Adelman | EXECUTIVE VP, DEVELOPMENT | 0.00 | $22.85 | -$267.98K | SELL-OPTIONS | 0.00% | 8.28K | Dec 04 | View |
| Dec 03, 2003 | William Rohn | EXEC VP & COO | 0.00 | $22.59 | -$1.64M | SELL-OPTIONS | 0.00% | 377.39K | Dec 02 | View |
| Nov 20, 2003 | Connie Matsui | SR V P, PLANNING& RESOURCE DEV | 0.00 | $20.23 | -$1.19M | SELL-OPTIONS | 0.00% | 165.40K | Nov 19 | View |
| Nov 14, 2003 | Bruce Ross | DIRECTOR | 0.00 | $19.90 | -$761.83K | SELL-OPTIONS | 0.00% | 0.00 | Nov 13 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
BIIB Insider Trading News
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved